Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Tuberculosis

  Free Subscription


Articles published in Int J Tuberc Lung Dis

Retrieve available abstracts of 479 articles:
HTML format
Text format



Single Articles


    June 2017
  1. DELGADO E, Monedero I, Bhavaraju R
    Resilience and extensively drug-resistant tuberculosis: the unlikely ally.
    Int J Tuberc Lung Dis. 2017;21:713-716.
    PubMed     Text format     Abstract available


  2. SIVAKUMAR P, Marples L, Breen R, Ahmed L, et al
    The diagnostic utility of pleural fluid adenosine deaminase for tuberculosis in a low prevalence area.
    Int J Tuberc Lung Dis. 2017;21:697-701.
    PubMed     Text format     Abstract available


  3. TELISINGHE L, Amofa-Sekyi M, Maluzi K, Kaluba-Milimo D, et al
    The sensitivity of the QuantiFERON(R)-TB Gold Plus assay in Zambian adults with active tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:690-696.
    PubMed     Text format     Abstract available


  4. BARR DA, Coussens AK, Irvine S, Ritchie ND, et al
    Paradoxical upgrading reaction in extra-pulmonary tuberculosis: association with vitamin D therapy.
    Int J Tuberc Lung Dis. 2017;21:677-683.
    PubMed     Text format     Abstract available


  5. VAN DER HEIJDEN YF, Karim F, Mufamadi G, Zako L, et al
    Isoniazid-monoresistant tuberculosis is associated with poor treatment outcomes in Durban, South Africa.
    Int J Tuberc Lung Dis. 2017;21:670-676.
    PubMed     Text format     Abstract available


  6. PATSCHE CB, Rudolf F, Mogensen SW, Sifna A, et al
    Low prevalence of malnourishment among household contacts of patients with tuberculosis in Guinea-Bissau.
    Int J Tuberc Lung Dis. 2017;21:664-669.
    PubMed     Text format     Abstract available


  7. STENNIS NL, Meissner JS, Bhavnani D, Kreiswirth B, et al
    Tuberculosis disease among Mexico-born individuals living in New York City, 2001-2014.
    Int J Tuberc Lung Dis. 2017;21:657-663.
    PubMed     Text format     Abstract available


  8. SNOW K, Hesseling AC, Naidoo P, Graham SM, et al
    Tuberculosis in adolescents and young adults: epidemiology and treatment outcomes in the Western Cape.
    Int J Tuberc Lung Dis. 2017;21:651-657.
    PubMed     Text format     Abstract available


  9. KALRA A
    Care seeking and treatment related delay among childhood tuberculosis patients in Delhi, India.
    Int J Tuberc Lung Dis. 2017;21:645-650.
    PubMed     Text format     Abstract available


  10. ZIEMELE B, Ranka R, Ozere I
    Pediatric and adolescent tuberculosis in Latvia, 2011-2014: case detection, diagnosis and treatment.
    Int J Tuberc Lung Dis. 2017;21:637-645.
    PubMed     Text format     Abstract available


  11. LONNROTH K, Mor Z, Erkens C, Bruchfeld J, et al
    Tuberculosis in migrants in low-incidence countries: epidemiology and intervention entry points.
    Int J Tuberc Lung Dis. 2017;21:624-637.
    PubMed     Text format     Abstract available


  12. DHAVAN P, Dias HM, Creswell J, Weil D, et al
    An overview of tuberculosis and migration.
    Int J Tuberc Lung Dis. 2017;21:610-623.
    PubMed     Text format     Abstract available


  13. WALKER IF, Baral SC, Wei X, Huque R, et al
    Multidrug-resistant tuberculosis treatment programmes insufficiently consider comorbid mental disorders.
    Int J Tuberc Lung Dis. 2017;21:603-609.
    PubMed     Text format     Abstract available


  14. SEDDON JA, Gie RP
    If you look, you will find: time to challenge the childhood tuberculosis paradigm.
    Int J Tuberc Lung Dis. 2017;21:602.
    PubMed     Text format    


  15. RAVIGLIONE MC, Mosca D
    Migrant health and tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:599-600.
    PubMed     Text format    


    May 2017
  16. J-Y FENG JY, Jarlsberg LG, Salcedo K, Rose J, et al
    Clinical and bacteriological characteristics associated with clustering of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2017 May 16. doi: 10.5588/ijtld.16.0510.
    PubMed     Text format     Abstract available


  17. ARSCOTT-MILLS T, Masole L, Ncube R, Steenhoff AP, et al
    Survey of health care worker knowledge about childhood tuberculosis in high-burden centers in Botswana.
    Int J Tuberc Lung Dis. 2017;21:586-591.
    PubMed     Text format     Abstract available


  18. SCOTT C, Mangan J, Tillova Z, Jensen PA, et al
    Evaluation of the Tuberculosis Infection Control Training Center, Tajikistan, 2014-2015.
    Int J Tuberc Lung Dis. 2017;21:579-585.
    PubMed     Text format     Abstract available


  19. ADAMS LV, Basu D, Grande SW, Craig SR, et al
    Barriers to tuberculosis care delivery among miners and their families in South Africa: an ethnographic study.
    Int J Tuberc Lung Dis. 2017;21:571-578.
    PubMed     Text format     Abstract available


  20. UKWAJA KN, Alobu I, Gidado M, Onazi O, et al
    Economic support intervention improves tuberculosis treatment outcomes in rural Nigeria.
    Int J Tuberc Lung Dis. 2017;21:564-570.
    PubMed     Text format     Abstract available


  21. LOVEDAY M, Ramjee A, Osburn G, Master I, et al
    Drug-resistant tuberculosis in patients with minimal symptoms: favourable outcomes in the absence of treatment.
    Int J Tuberc Lung Dis. 2017;21:556-563.
    PubMed     Text format     Abstract available


  22. DALE KD, Globan M, Tay EL, Trauer JM, et al
    Recurrence of tuberculosis in a low-incidence setting without directly observed treatment: Victoria, Australia, 2002-2014.
    Int J Tuberc Lung Dis. 2017;21:550-555.
    PubMed     Text format     Abstract available


  23. MAHARAJ B, Gengiah TN, Yende-Zuma N, Gengiah S, et al
    Implementing isoniazid preventive therapy in a tuberculosis treatment-experienced cohort on ART.
    Int J Tuberc Lung Dis. 2017;21:537-543.
    PubMed     Text format     Abstract available


  24. SSENGOOBA W, Lukoye D, Meehan CJ, Kateete DP, et al
    Tuberculosis resistance-conferring mutations with fitness cost among HIV-positive individuals in Uganda.
    Int J Tuberc Lung Dis. 2017;21:531-536.
    PubMed     Text format     Abstract available


  25. SATAKE Y, Nakamura Y, Kono M, Hozumi H, et al
    Type-1 polarised dendritic cells are a potent immunogen against Mycobacterium tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:523-530.
    PubMed     Text format     Abstract available


  26. RONALD LA, Ling DI, FitzGerald JM, Schwartzman K, et al
    Validated methods for identifying tuberculosis patients in health administrative databases: systematic review.
    Int J Tuberc Lung Dis. 2017;21:517-522.
    PubMed     Text format     Abstract available


  27. FENG JY, Jarlsberg LG, Rose J, Grinsdale JA, et al
    Impact of Euro-American sublineages of Mycobacterium tuberculosis on new infections among named contacts.
    Int J Tuberc Lung Dis. 2017;21:509-516.
    PubMed     Text format     Abstract available


  28. HO J, Jelfs P, Nguyen PT, Sintchenko V, et al
    Pooling sputum samples to improve the feasibility of Xpert(R) MTB/RIF in systematic screening for tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:503-508.
    PubMed     Text format     Abstract available


  29. VAN AART C, Boshuizen H, Dekkers A, Korthals Altes H, et al
    Time lag between immigration and tuberculosis rates in immigrants in the Netherlands: a time-series analysis.
    Int J Tuberc Lung Dis. 2017;21:486-492.
    PubMed     Text format     Abstract available


  30. POSEY DL, Marano N, Cetron MS
    Cross-border solutions needed to address tuberculosis in migrating populations.
    Int J Tuberc Lung Dis. 2017;21:485-486.
    PubMed     Text format    


  31. YATES TA, Atkinson SH
    Ironing out sex differences in tuberculosis prevalence.
    Int J Tuberc Lung Dis. 2017;21:483-484.
    PubMed     Text format    


    April 2017
  32. JAIN A, Singh PK, Singh U, Kumar V, et al
    Initial screening of extra-pulmonary tuberculosis using the Xpert MTB/RIF assay improves case detection rates.
    Int J Tuberc Lung Dis. 2017;21:478-480.
    PubMed     Text format    


  33. CHONG SG, Herron M, Dorman A, Little M, et al
    Renal amyloidosis complicating multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:476-477.
    PubMed     Text format    


  34. BLOK L, Bakker MI, Straetemans M, Gerstel L, et al
    Should active case-finding projects increase the number of tuberculosis cases notified at national level?
    Int J Tuberc Lung Dis. 2017;21:475.
    PubMed     Text format    


  35. WEBER SF, Belard S, Rai S, Reddy R, et al
    Immune thrombocytopenia secondary to tuberculosis: a case and review of literature.
    Int J Tuberc Lung Dis. 2017;21:466-470.
    PubMed     Text format     Abstract available


  36. VALENCIA S, Respeito D, Blanco S, Ribeiro RM, et al
    Tuberculosis drug resistance in Southern Mozambique: results of a population-level survey in the district of Manhica.
    Int J Tuberc Lung Dis. 2017;21:446-451.
    PubMed     Text format     Abstract available


  37. ADLER H, Archary M, Mahabeer P, LaRussa P, et al
    Tuberculosis in HIV-infected South African children with complicated severe acute malnutrition.
    Int J Tuberc Lung Dis. 2017;21:438-445.
    PubMed     Text format     Abstract available


  38. CARTER KL, Gabrellas AD, Shah S, Garland JM, et al
    Improved latent tuberculosis therapy completion rates in refugee patients through use of a clinical pharmacist.
    Int J Tuberc Lung Dis. 2017;21:432-437.
    PubMed     Text format     Abstract available


  39. ARMENTA RF, Collins KM, Strathdee SA, Bulterys MA, et al
    Mycobacterium tuberculosis infection among persons who inject drugs in San Diego, California.
    Int J Tuberc Lung Dis. 2017;21:425-431.
    PubMed     Text format     Abstract available


  40. SHAIKH N, Gupte A, Dharmshale S, Pokkali S, et al
    Novel interferon-gamma assays for diagnosing tuberculosis in young children in India.
    Int J Tuberc Lung Dis. 2017;21:412-419.
    PubMed     Text format     Abstract available


  41. VAN WYK SS, Lin HH, Claassens MM
    A systematic review of prediction models for prevalent pulmonary tuberculosis in adults.
    Int J Tuberc Lung Dis. 2017;21:405-411.
    PubMed     Text format     Abstract available


  42. OWUSU-EDUSEI K, Marks SM, Miramontes R, Stockbridge EL, et al
    Tuberculosis hospitalization expenditures per patient from private health insurance claims data, 2010-2014.
    Int J Tuberc Lung Dis. 2017;21:398-404.
    PubMed     Text format     Abstract available


  43. RUPERT S, Vassall A, Raizada N, Khaparde SD, et al
    Bottom-up or top-down: unit cost estimation of tuberculosis diagnostic tests in India.
    Int J Tuberc Lung Dis. 2017;21:375-380.
    PubMed     Text format     Abstract available


  44. PANDEY S, Chadha VK, Laxminarayan R, Arinaminpathy N, et al
    Estimating tuberculosis incidence from primary survey data: a mathematical modeling approach.
    Int J Tuberc Lung Dis. 2017;21:366-374.
    PubMed     Text format     Abstract available


  45. DODD PJ
    Tracking tuberculosis incidence: time to tool up.
    Int J Tuberc Lung Dis. 2017;21:363.
    PubMed     Text format    


    March 2017
  46. ZHANG ZX, Sng LH, Yong Y, Lin LM, et al
    Delays in diagnosis and treatment of pulmonary tuberculosis in AFB smear-negative patients with pneumonia.
    Int J Tuberc Lung Dis. 2017 Mar 16. doi: 10.5588/ijtld.16.0667.
    PubMed     Text format     Abstract available


  47. MASJEDI MR, Hosseini M, Aryanpur M, Mortaz E, et al
    The effects of smoking on treatment outcome in patients newly diagnosed with pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:351-356.
    PubMed     Text format     Abstract available


  48. BOONYAGARS L, Hirunwiwatkul P, Hurst CP
    CD4 count and risk of anti-tuberculosis drug-associated cutaneous reactions in HIV-infected Thai patients.
    Int J Tuberc Lung Dis. 2017;21:338-344.
    PubMed     Text format     Abstract available


  49. DIAS M, Gaio R, Sousa P, Abranches M, et al
    Tuberculosis among the homeless: should we change the strategy?
    Int J Tuberc Lung Dis. 2017;21:327-332.
    PubMed     Text format     Abstract available


  50. O'HARA LM, Yassi A, Bryce EA, van Rensburg AJ, et al
    Infection control and tuberculosis in health care workers: an assessment of 28 hospitals in South Africa.
    Int J Tuberc Lung Dis. 2017;21:320-326.
    PubMed     Text format     Abstract available


  51. HUERGA H, Bastard M, Kamene M, Wanjala S, et al
    Outcomes from the first multidrug-resistant tuberculosis programme in Kenya.
    Int J Tuberc Lung Dis. 2017;21:314-319.
    PubMed     Text format     Abstract available


  52. JAVAID A, Hasan R, Zafar A, Chaudry MA, et al
    Pattern of first- and second-line drug resistance among pulmonary tuberculosis retreatment cases in Pakistan.
    Int J Tuberc Lung Dis. 2017;21:303-308.
    PubMed     Text format     Abstract available


  53. FOX GJ, Anh NT, Nhung NV, Loi NT, et al
    Latent tuberculous infection in household contacts of multidrug-resistant and newly diagnosed tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:297-302.
    PubMed     Text format     Abstract available


  54. KAMAKIA R, Kiazyk S, Waruk J, Meyers A, et al
    Potential biomarkers associated with discrimination between latent and active pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:278-285.
    PubMed     Text format     Abstract available


  55. NAUSCH N, Lundtoft C, Schulz G, Henckel H, et al
    Multiple cytokines for the detection of Mycobacterium tuberculosis infection in children with tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:270-277.
    PubMed     Text format     Abstract available


  56. DONNAN EJ, Coulter C, Simpson G, Clark J, et al
    Paediatric tuberculosis in Queensland, Australia: overrepresentation of cross-border and Indigenous children.
    Int J Tuberc Lung Dis. 2017;21:263-269.
    PubMed     Text format     Abstract available


  57. CRANMER LM, Langat A, Ronen K, McGrath CJ, et al
    Integrating tuberculosis screening in Kenyan Prevention of Mother-To-Child Transmission programs.
    Int J Tuberc Lung Dis. 2017;21:256-262.
    PubMed     Text format     Abstract available


  58. REICHMAN LB
    The tuberculosis taboo.
    Int J Tuberc Lung Dis. 2017;21:251-255.
    PubMed     Text format     Abstract available


    February 2017
  59. PRIYADARSHINI P, Tiwari K, Das A, Kumar D, et al
    Evaluation of highly conserved hsp65-specific nested PCR primers for diagnosing Mycobacterium tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:214-217.
    PubMed     Text format     Abstract available


  60. MCEBULA V, Crowther NJ, Nagel SE, George JA, et al
    Diabetes and abnormal glucose tolerance in subjects with tuberculosis in a South African urban center.
    Int J Tuberc Lung Dis. 2017;21:208-213.
    PubMed     Text format     Abstract available


  61. BRYLA M, Dziankowska-Zaborszczyk E, Maniecka-Bryla I
    Standard expected years of life lost due to tuberculosis in Poland.
    Int J Tuberc Lung Dis. 2017;21:202-207.
    PubMed     Text format     Abstract available


  62. CLAASSENS MM, Dunbar R, Yang B, Lombard CJ, et al
    Scanty smears associated with initial loss to follow-up in South African tuberculosis patients.
    Int J Tuberc Lung Dis. 2017;21:196-201.
    PubMed     Text format     Abstract available


  63. IZUMI K, Ohkado A, Uchimura K, Kawatsu L, et al
    Evaluation of tuberculosis contact investigations in Japan.
    Int J Tuberc Lung Dis. 2017;21:188-195.
    PubMed     Text format     Abstract available


  64. HTET KK, Liabsuetrakul T, Thein S
    Cost-effectiveness of a new strategy to detect pulmonary tuberculosis in household contacts in Myanmar.
    Int J Tuberc Lung Dis. 2017;21:181-187.
    PubMed     Text format     Abstract available


  65. GUGLIELMETTI L, Hewison C, Avaliani Z, Hughes J, et al
    Examples of bedaquiline introduction for the management of multidrug-resistant tuberculosis in five countries.
    Int J Tuberc Lung Dis. 2017;21:167-174.
    PubMed     Text format     Abstract available


  66. CHIPINDURO M, Mateveke K, Makamure B, Ferrand RA, et al
    Stool Xpert(R) MTB/RIF test for the diagnosis of childhood pulmonary tuberculosis at primary clinics in Zimbabwe.
    Int J Tuberc Lung Dis. 2017;21:161-166.
    PubMed     Text format     Abstract available


  67. CHIANG SS, Roche S, Contreras C, Del Castillo H, et al
    Barriers to the treatment of childhood tuberculous infection and tuberculosis disease: a qualitative study.
    Int J Tuberc Lung Dis. 2017;21:154-160.
    PubMed     Text format     Abstract available


  68. LOPEZ C, Bertram-Farough A, Heywood D, Dawson L, et al
    Knowing about you: eliciting dimensions of personhood within tuberculosis care.
    Int J Tuberc Lung Dis. 2017;21:149-153.
    PubMed     Text format     Abstract available


  69. PARENT SN, Ehrlich R, Baxter V, Kannemeyer N, et al
    Participatory theatre and tuberculosis: a feasibility study with South African health care workers.
    Int J Tuberc Lung Dis. 2017;21:140-148.
    PubMed     Text format     Abstract available


  70. STAGG HR, Lipman MC, McHugh TD, Jenkins HE, et al
    Isoniazid-resistant tuberculosis: a cause for concern?
    Int J Tuberc Lung Dis. 2017;21:129-139.
    PubMed     Text format     Abstract available


    January 2017
  71. RIEDER HL, Van Deun A
    Rationale for high-dose isoniazid in the treatment of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:123-124.
    PubMed     Text format    


  72. REVES R, Benjamin R
    The cost of the failure to eliminate tuberculosis in the United States.
    Int J Tuberc Lung Dis. 2017;21:120.
    PubMed     Text format    


  73. KUMAR NP, Velayutham B, Nair D, Babu S, et al
    Angiopoietins as biomarkers of disease severity and bacterial burden in pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:93-99.
    PubMed     Text format     Abstract available


  74. DAVIS A, Terlikbayeva A, Aifah A, Hermosilla S, et al
    Risks for tuberculosis in Kazakhstan: implications for prevention.
    Int J Tuberc Lung Dis. 2017;21:86-92.
    PubMed     Text format     Abstract available


  75. SHAWENO D, Shaweno T, Trauer JM, Denholm JT, et al
    Heterogeneity of distribution of tuberculosis in Sheka Zone, Ethiopia: drivers and temporal trends.
    Int J Tuberc Lung Dis. 2017;21:79-85.
    PubMed     Text format     Abstract available


  76. KOURA KG, Trebucq A, Schwoebel V
    Do active case-finding projects increase the number of tuberculosis cases notified at national level?
    Int J Tuberc Lung Dis. 2017;21:73-78.
    PubMed     Text format     Abstract available


  77. RUDOLF F, Wagner AJ, Back FM, Gomes VF, et al
    Tuberculosis case finding and mortality prediction: added value of the clinical TBscore and biomarker suPAR.
    Int J Tuberc Lung Dis. 2017;21:67-72.
    PubMed     Text format     Abstract available


  78. RAGONNET R, Trauer JM, McBryde ES, Houben RM, et al
    Is IPT more effective in high-burden settings? Modelling the effect of tuberculosis incidence on IPT impact.
    Int J Tuberc Lung Dis. 2017;21:60-66.
    PubMed     Text format     Abstract available


  79. CHABALA C, Chongwe G, Jumbe-Marsden E, Somwe SW, et al
    Missed opportunities for screening child contacts of smear-positive tuberculosis in Zambia, a high-prevalence setting.
    Int J Tuberc Lung Dis. 2017;21:53-59.
    PubMed     Text format     Abstract available


  80. EGERE U, Togun T, Sillah A, Mendy F, et al
    Identifying children with tuberculosis among household contacts in The Gambia.
    Int J Tuberc Lung Dis. 2017;21:46-52.
    PubMed     Text format     Abstract available


  81. ZELDOW B, Kim S, McSherry G, Cotton MF, et al
    Use of antiretrovirals in HIV-infected children in a tuberculosis prevention trial: IMPAACT P1041.
    Int J Tuberc Lung Dis. 2017;21:38-45.
    PubMed     Text format     Abstract available


  82. JERENE D, Abebe W, Taye K, Suarez PG, et al
    Tuberculosis along the continuum of HIV care in a cohort of adolescents living with HIV in Ethiopia.
    Int J Tuberc Lung Dis. 2017;21:32-37.
    PubMed     Text format     Abstract available


  83. TUPASI T, Garfin AM, Mangan JM, Orillaza-Chi R, et al
    Multidrug-resistant tuberculosis patients' views of interventions to reduce treatment loss to follow-up.
    Int J Tuberc Lung Dis. 2017;21:23-31.
    PubMed     Text format     Abstract available


  84. WELDEGEBREAL S, Mebrahtu T
    Anti-tuberculosis drug resistance in Ethiopia: systematic review.
    Int J Tuberc Lung Dis. 2017;21:18-22.
    PubMed     Text format     Abstract available


  85. BANU S, Rahman MT, Ahmed S, Khatun R, et al
    Multidrug-resistant tuberculosis in Bangladesh: results from a sentinel surveillance system.
    Int J Tuberc Lung Dis. 2017;21:12-17.
    PubMed     Text format     Abstract available


  86. NOURZAD S, Jenkins HE, Milstein M, Mitnick CD, et al
    Estimating the global burden of multidrug-resistant tuberculosis among prevalent cases of tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:6-11.
    PubMed     Text format     Abstract available


  87. FURIN J, Diacon AH, Andries K
    Combating drug-resistant tuberculosis: the unexpected benefits of bedaquiline.
    Int J Tuberc Lung Dis. 2017;21:4-5.
    PubMed     Text format    


    December 2016
  88. STURKENBOOM MG, Bolhuis MS, Akkerman OW, de Lange WC, et al
    Therapeutic drug monitoring of first-line anti-tuberculosis drugs comprises more than C2h measurements.
    Int J Tuberc Lung Dis. 2016;20:1695-1696.
    PubMed     Text format    


  89. VELAYUTHAM B, Nair D, Kannan T, Padmapriyadarsini C, et al
    Factors associated with sputum culture conversion in multidrug-resistant pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1671-1676.
    PubMed     Text format     Abstract available


  90. SINGANAYAGAM A, Manalan K, Connell DW, Chalmers JD, et al
    Evaluation of serum inflammatory biomarkers as predictors of treatment outcome in pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1653-1660.
    PubMed     Text format     Abstract available


  91. EL AZBAOUI S, Sabri A, Ouraini S, Hassani A, et al
    Utility of the QuantiFERON-TB Gold In-Tube assay for the diagnosis of tuberculosis in Moroccan children.
    Int J Tuberc Lung Dis. 2016;20:1639-1646.
    PubMed     Text format     Abstract available


  92. CONNERS E, Garfein RS, Rodwell TC, Udwadia ZF, et al
    Mobility patterns of persons at risk for drug-resistant tuberculosis in Mumbai, India.
    Int J Tuberc Lung Dis. 2016;20:1633-1638.
    PubMed     Text format     Abstract available


  93. ZELNICK JR, O'Donnell MR, Ahuja SD, Chua A, et al
    Health care provider perspectives on tuberculosis care for foreign-born populations in New York City.
    Int J Tuberc Lung Dis. 2016;20:1625-1632.
    PubMed     Text format     Abstract available


  94. BRIGHT-THOMAS RJ, Gondker AR, Morris J, Ormerod LP, et al
    Drug-related hepatitis in patients treated with standard anti-tuberculosis chemotherapy over a 30-year period.
    Int J Tuberc Lung Dis. 2016;20:1621-1624.
    PubMed     Text format     Abstract available


  95. RENDELL NL, Batjargal N, Jadambaa N, Dobler CC, et al
    Risk of tuberculosis during pregnancy in Mongolia, a high incidence setting with low HIV prevalence.
    Int J Tuberc Lung Dis. 2016;20:1615-1620.
    PubMed     Text format     Abstract available


  96. MBATCHOU NGAHANE BH, Dahirou F, Tchieche C, Wandji A, et al
    Clinical characteristics and outcomes of tuberculosis in Douala, Cameroon: a 7-year retrospective cohort study.
    Int J Tuberc Lung Dis. 2016;20:1609-1614.
    PubMed     Text format     Abstract available


  97. SIROKA A, Law I, Macinko J, Floyd K, et al
    The effect of household poverty on tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1603-1608.
    PubMed     Text format     Abstract available


  98. MARGALIT I, Block C, Mor Z
    Seasonality of tuberculosis in Israel, 20012011.
    Int J Tuberc Lung Dis. 2016;20:1588-1593.
    PubMed     Text format     Abstract available


  99. JENSEN SG, Lillebaek T, Wilcke T, Pedersen MK, et al
    Impact of contact investigation and tuberculosis screening among high-risk groups in Denmark.
    Int J Tuberc Lung Dis. 2016;20:1580-1587.
    PubMed     Text format     Abstract available


  100. CASTRO KG
    Detection and treatment of persons with latent tuberculosis infection: first eliminate the policy-to-practice gap.
    Int J Tuberc Lung Dis. 2016;20:1565.
    PubMed     Text format    


  101. TALAVERA-PAULIN M, Garcia-Morales L, Ruiz-Sanchez BP, Caamal-Ley AD, et al
    Active tuberculosis patients have high levels of IgA anti-alpha-crystallin and isocitrate lyase proteins.
    Int J Tuberc Lung Dis. 2016;20:1681-1688.
    PubMed     Text format     Abstract available


  102. EL AZBAOUI S, Sabri A, Ouraini S, Hassani A, et al
    Utility of the QuantiFERON(R)-TB Gold In-Tube assay for the diagnosis of tuberculosis in Moroccan children.
    Int J Tuberc Lung Dis. 2016;20:1639-1646.
    PubMed     Text format     Abstract available


  103. MBATCHOU NGAHANE BH, Dahirou F, Tchieche C, Wandji A, et al
    Clinical characteristics and outcomes of tuberculosis in Douala, Cameroon: a 7-year retrospective cohort study.
    Int J Tuberc Lung Dis. 2016;20:1609-1614.
    PubMed     Text format     Abstract available


  104. MARGALIT I, Block C, Mor Z
    Seasonality of tuberculosis in Israel, 2001-2011.
    Int J Tuberc Lung Dis. 2016;20:1588-1593.
    PubMed     Text format     Abstract available


  105. BRUGUERAS S, Orcau A, Millet JP, Espinosa L, et al
    Tuberculosis clinical units improve contact tracing.
    Int J Tuberc Lung Dis. 2016;20:1572-1579.
    PubMed     Text format     Abstract available


  106. O'DONNELL MR, Padayatchi N, Metcalfe JZ
    Elucidating the role of clofazimine for the treatment of tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:52-57.
    PubMed     Text format     Abstract available


  107. NUERMBERGER E
    Evolving strategies for dose optimization of linezolid for treatment of tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:48-51.
    PubMed     Text format     Abstract available


  108. STERLING TR
    Fluoroquinolones for the treatment and prevention of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:42-47.
    PubMed     Text format     Abstract available


  109. MURRAY S, Mendel C, Spigelman M
    TB Alliance regimen development for multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:38-41.
    PubMed     Text format     Abstract available


  110. GUPTA R, Wells CD, Hittel N, Hafkin J, et al
    Delamanid in the treatment of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:33-37.
    PubMed     Text format     Abstract available


  111. MILSTEIN M, Brzezinski A, Varaine F, Mitnick CD, et al
    (Re)moving the needle: prospects for all-oral treatment for multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:18-23.
    PubMed     Text format     Abstract available


    November 2016
  112. DHOLAKIA Y, Mistry N
    Active tuberculosis case finding in a migrant slum community, Mumbai, India.
    Int J Tuberc Lung Dis. 2016;20:1562.
    PubMed     Text format    


  113. LEVIN A, Sklyuev S, Felker I, Tceymach E, et al
    Endobronchial valve treatment of destructive multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1539-1545.
    PubMed     Text format     Abstract available


  114. PINA RZ, Caleffi-Ferracioli KR, Campanerut-Sa PA, Ghiraldi-Lopez LD, et al
    Pyrazinamide susceptibility testing in Mycobacterium tuberculosis using the fast resazurin microtiter assay plate.
    Int J Tuberc Lung Dis. 2016;20:1535-1538.
    PubMed     Text format     Abstract available


  115. ALIPANAH N, Cattamanchi A, Menzies R, Hopewell PC, et al
    Treatment of non-cavitary pulmonary tuberculosis with shortened fluoroquinolone-based regimens: a meta-analysis.
    Int J Tuberc Lung Dis. 2016;20:1522-1528.
    PubMed     Text format     Abstract available


  116. KIM CH, Lim JK, Lee DH, Yoo SS, et al
    Outcomes of standard and tailored anti-tuberculosis regimens in patients with tuberculous pleural effusion.
    Int J Tuberc Lung Dis. 2016;20:1516-1521.
    PubMed     Text format     Abstract available


  117. IGLECIAS LM, Puga MA, Pompilio MA, Teles SA, et al
    Epidemiological study of hepatitis B virus among prisoners with active tuberculosis in Central Brazil.
    Int J Tuberc Lung Dis. 2016;20:1509-1515.
    PubMed     Text format     Abstract available


  118. IZUMI K, Kawatsu L, Ohkado A, Uchimura K, et al
    Evaluating the impact of health resource reconstruction on improving spatial accessibility of tuberculosis care.
    Int J Tuberc Lung Dis. 2016;20:1501-1508.
    PubMed     Text format     Abstract available


  119. LOPEZ AL, Aldaba JG, Ama CG, Sylim PG, et al
    Surveillance for tuberculosis in a rural community in The Philippines.
    Int J Tuberc Lung Dis. 2016;20:1495-1500.
    PubMed     Text format     Abstract available


  120. NOESKE J, Nana Yakam A, Abena Foe JL
    Epidemiology of tuberculosis in Cameroon as mirrored in notification data, 2006-2014.
    Int J Tuberc Lung Dis. 2016;20:1489-1494.
    PubMed     Text format     Abstract available


  121. DAFTARY A, Padayatchi N
    Provider perspectives on drug-resistant tuberculosis and human immunodeficiency virus care in South Africa: a qualitative case study.
    Int J Tuberc Lung Dis. 2016;20:1483-1488.
    PubMed     Text format     Abstract available


  122. MIBEI DJ, Kiarie JW, Wairia A, Kamene M, et al
    Treatment outcomes of drug-resistant tuberculosis patients in Kenya.
    Int J Tuberc Lung Dis. 2016;20:1477-1482.
    PubMed     Text format     Abstract available


  123. GARCIA-PRATS AJ, du Plessis L, Draper HR, Burger A, et al
    Outcome of culture-confirmed isoniazid-resistant rifampicin-susceptible tuberculosis in children.
    Int J Tuberc Lung Dis. 2016;20:1469-1476.
    PubMed     Text format     Abstract available


  124. CHAYA S, Dangor Z, Solomon F, Nzenze SA, et al
    Incidence of tuberculosis meningitis in a high HIV prevalence setting: time-series analysis from 2006 to 2011.
    Int J Tuberc Lung Dis. 2016;20:1457-1462.
    PubMed     Text format     Abstract available


  125. TURKOVA A, Chappell E, Chalermpantmetagul S, Negra MD, et al
    Tuberculosis in HIV-infected children in Europe, Thailand and Brazil: paediatric TB-HIV EuroCoord study.
    Int J Tuberc Lung Dis. 2016;20:1448-1456.
    PubMed     Text format     Abstract available


  126. JAGANATH D, Lamichhane G, Shah M
    Carbapenems against Mycobacterium tuberculosis: a review of the evidence.
    Int J Tuberc Lung Dis. 2016;20:1436-1447.
    PubMed     Text format     Abstract available


  127. UPLEKAR M
    Public-private mix for tuberculosis care and prevention. What progress? What prospects?
    Int J Tuberc Lung Dis. 2016;20:1424-1429.
    PubMed     Text format     Abstract available


    October 2016
  128. NUNN A, Tweed C
    Treatment regimens for rifampicin-resistant tuberculosis: highlighting a research gap.
    Int J Tuberc Lung Dis. 2016;20:1418-1419.
    PubMed     Text format    


  129. KARAKAS A, Turhan V, Esquinas AM
    Reasons for high mortality rates in patients with pulmonary tuberculosis needing mechanical ventilation.
    Int J Tuberc Lung Dis. 2016;20:1416-1417.
    PubMed     Text format    


  130. FRIEDEN TR
    Positive bacteriological results among contacts of patients with active tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1416.
    PubMed     Text format    


  131. NAIDOO P, Dunbar R, du Toit E, van Niekerk M, et al
    Comparing laboratory costs of smear/culture and Xpert(R) MTB/RIF-based tuberculosis diagnostic algorithms.
    Int J Tuberc Lung Dis. 2016;20:1377-1385.
    PubMed     Text format     Abstract available


  132. ZHAO Q, Xiao X, Lu W, Qiu LX, et al
    Screening diabetes in tuberculosis patients in eastern rural China: a community-based cross-sectional study.
    Int J Tuberc Lung Dis. 2016;20:1370-1376.
    PubMed     Text format     Abstract available


  133. WATTANAPOKAYAKIT S, Mushiroda T, Yanai H, Wichukchinda N, et al
    NAT2 slow acetylator associated with anti-tuberculosis drug-induced liver injury in Thai patients.
    Int J Tuberc Lung Dis. 2016;20:1364-1369.
    PubMed     Text format     Abstract available


  134. THIEL BA, Bark CM, Nakibali JG, van der Kuyp F, et al
    Reader variability and validation of the Timika X-ray score during treatment of pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1358-1363.
    PubMed     Text format     Abstract available


  135. PARCHURE R, Kulkarni V, Gangakhedkar R, Swaminathan S, et al
    Treatment outcomes of daily anti-tuberculosis treatment in HIV-infected patients seeking care at a private clinic in India.
    Int J Tuberc Lung Dis. 2016;20:1348-1353.
    PubMed     Text format     Abstract available


  136. TOLLEFSON D, Ngari F, Mwakala M, Gethi D, et al
    Under-reporting of sputum smear-positive tuberculosis cases in Kenya.
    Int J Tuberc Lung Dis. 2016;20:1334-1341.
    PubMed     Text format     Abstract available


  137. SENKORO M, Kumar AM, Chinnakali P, Mfinanga SG, et al
    Population impact of factors associated with prevalent pulmonary tuberculosis in Tanzania.
    Int J Tuberc Lung Dis. 2016;20:1326-1333.
    PubMed     Text format     Abstract available


  138. ENANE LA, Lowenthal ED, Arscott-Mills T, Matlhare M, et al
    Loss to follow-up among adolescents with tuberculosis in Gaborone, Botswana.
    Int J Tuberc Lung Dis. 2016;20:1320-1325.
    PubMed     Text format     Abstract available


  139. STILLSON CH, Okatch H, Frasso R, Mazhani L, et al
    'That's when I struggle' ... Exploring challenges faced by care givers of children with tuberculosis in Botswana.
    Int J Tuberc Lung Dis. 2016;20:1314-1319.
    PubMed     Text format     Abstract available


  140. SULIS G, Gnanou S, Roggi A, Konseimbo A, et al
    Active tuberculosis case finding among pregnant women: a pilot project in Burkina Faso.
    Int J Tuberc Lung Dis. 2016;20:1306-1308.
    PubMed     Text format     Abstract available


  141. MUNANG ML, Browne C, Evans JT, Smith EG, et al
    Programmatic utility of tuberculosis cluster investigation using a social network approach in Birmingham, United Kingdom.
    Int J Tuberc Lung Dis. 2016;20:1300-1305.
    PubMed     Text format     Abstract available


  142. TEBRUEGGE M, Buonsenso D, Brinkmann F, Noguera-Julian A, et al
    European shortage of purified protein derivative and its impact on tuberculosis screening practices.
    Int J Tuberc Lung Dis. 2016;20:1293-1299.
    PubMed     Text format     Abstract available


  143. TREBUCQ A, Schwoebel V
    Numbers of tuberculosis cases: dreams and reality.
    Int J Tuberc Lung Dis. 2016;20:1288-1292.
    PubMed     Text format     Abstract available


  144. LONG R, Lau A
    How R G Ferguson's groundbreaking studies influenced our understanding of tuberculosis reinfection. Where to next?
    Int J Tuberc Lung Dis. 2016;20:1285-1287.
    PubMed     Text format    


  145. LONNROTH K, Shah NS, Lange C
    State-of-the-art series on tuberculosis and migration.
    Int J Tuberc Lung Dis. 2016;20:1280-1281.
    PubMed     Text format    


    September 2016
  146. EILERTSON B, Maruri F, Blackman A, Herrera M, et al
    Reversion of phenotypic fluoroquinolone resistance in Mycobacterium tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1276-7.
    PubMed     Text format    


  147. OTTO-KNAPP R, Vesenbeckh S, Schonfeld N, Bettermann G, et al
    Isoniazid minimal inhibitory concentrations of tuberculosis strains with katG mutation.
    Int J Tuberc Lung Dis. 2016;20:1275-6.
    PubMed     Text format    


  148. HEMANTH KUMAR AK, Kannan T, Chandrasekaran V, Sudha V, et al
    Pharmacokinetics of thrice-weekly rifampicin, isoniazid and pyrazinamide in adult tuberculosis patients in India.
    Int J Tuberc Lung Dis. 2016;20:1236-41.
    PubMed     Text format     Abstract available


  149. PANDE T, Cohen C, Pai M, Ahmad Khan F, et al
    Computer-aided detection of pulmonary tuberculosis on digital chest radiographs: a systematic review.
    Int J Tuberc Lung Dis. 2016;20:1226-30.
    PubMed     Text format     Abstract available


  150. NUNES C, Taylor BM
    Modelling the time to detection of urban tuberculosis in two big cities in Portugal: a spatial survival analysis.
    Int J Tuberc Lung Dis. 2016;20:1219-25.
    PubMed     Text format     Abstract available


  151. MANGAN JM, Tupasi TE, Garfin AM, Lofranco V, et al
    Multidrug-resistant tuberculosis patients lost to follow-up: self-reported readiness to restart treatment.
    Int J Tuberc Lung Dis. 2016;20:1205-11.
    PubMed     Text format     Abstract available


  152. KWEDI NOLNA S, Kammogne ID, Ndzinga R, Afanda B, et al
    Community knowledge, attitudes and practices in relation to tuberculosis in Cameroon.
    Int J Tuberc Lung Dis. 2016;20:1199-204.
    PubMed     Text format     Abstract available


  153. DEMEMEW ZG, Habte D, Melese M, Hamusse SD, et al
    Trends in tuberculosis case notification and treatment outcomes after interventions in 10 zones of Ethiopia.
    Int J Tuberc Lung Dis. 2016;20:1192-8.
    PubMed     Text format     Abstract available


  154. KAPLAN R, Caldwell J, Hermans S, Adriaanse S, et al
    An integrated community TB-HIV adherence model provides an alternative to DOT for tuberculosis patients in Cape Town.
    Int J Tuberc Lung Dis. 2016;20:1185-91.
    PubMed     Text format     Abstract available


  155. JENKS JD, Kumarasamy N, Ezhilarasi C, Poongulali S, et al
    Improved tuberculosis outcomes with daily vs. intermittent rifabutin in HIV-TB coinfected patients in India.
    Int J Tuberc Lung Dis. 2016;20:1181-4.
    PubMed     Text format     Abstract available


  156. YHI JY, Park DW, Min JH, Park YK, et al
    Measurement of levels of fractional exhaled nitric oxide in patients with pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1174-80.
    PubMed     Text format     Abstract available


  157. BHATRAJU P, Patrawalla P, Trieu L, Ahuja SD, et al
    Errors in isolation of patients with infectious tuberculosis at a public teaching hospital in New York.
    Int J Tuberc Lung Dis. 2016;20:1168-73.
    PubMed     Text format     Abstract available


  158. RAO SA, Kadhiravan T, Swaminathan RP, Mahadevan S, et al
    Occupational exposure and tuberculosis among medical residents in a high-burden setting: an open-cohort study.
    Int J Tuberc Lung Dis. 2016;20:1162-7.
    PubMed     Text format     Abstract available


  159. TAYLOR JG, Yates TA, Mthethwa M, Tanser F, et al
    Measuring ventilation and modelling M. tuberculosis transmission in indoor congregate settings, rural KwaZulu-Natal.
    Int J Tuberc Lung Dis. 2016;20:1155-61.
    PubMed     Text format     Abstract available


  160. SUTHAR AB, Zachariah R, Harries AD
    Ending tuberculosis by 2030: can we do it?
    Int J Tuberc Lung Dis. 2016;20:1148-54.
    PubMed     Text format     Abstract available


  161. CHIANG CY, Van Deun A, Rieder HL
    Gatifloxacin for short, effective treatment of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1143-7.
    PubMed     Text format     Abstract available


  162. TWEED C, Nunn A
    Occupational exposure to tuberculosis in endemic areas: room for improvement.
    Int J Tuberc Lung Dis. 2016;20:1139.
    PubMed     Text format    


  163. SCARDIGLI A, Caminero JA
    Simple and practical measures to reduce tuberculosis transmission in public buildings.
    Int J Tuberc Lung Dis. 2016;20:1137-8.
    PubMed     Text format    


    August 2016
  164. DAUM LT, Fourie PB, Peters RP, Rodriguez JD, et al
    Xpert((R)) MTB/RIF detection of Mycobacterium tuberculosis from sputum collected in molecular transport medium.
    Int J Tuberc Lung Dis. 2016;20:1118-24.
    PubMed     Text format     Abstract available


  165. ATWEBEMBEIRE J, Orikiriza P, Bonnet M, Atwine D, et al
    Xpert((R)) MTB/RIF for detection of Mycobacterium tuberculosis from frozen string and induced sputum sediments.
    Int J Tuberc Lung Dis. 2016;20:1113-7.
    PubMed     Text format     Abstract available


  166. BOLLELA VR, Namburete EI, Feliciano CS, Macheque D, et al
    Detection of katG and inhA mutations to guide isoniazid and ethionamide use for drug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1099-104.
    PubMed     Text format     Abstract available


  167. MONTGOMERY CM
    Adaptive trials for tuberculosis: early reflections on theory and practice.
    Int J Tuberc Lung Dis. 2016;20:1091-8.
    PubMed     Text format     Abstract available


  168. STRINGER B, Lowton K, Tillashaikhov M, Parpieva N, et al
    'They prefer hidden treatment': anti-tuberculosis drug-taking practices and drug regulation in Karakalpakstan.
    Int J Tuberc Lung Dis. 2016;20:1084-90.
    PubMed     Text format     Abstract available


  169. TRIASIH R, Padmawati RS, Duke T, Robertson C, et al
    A mixed-methods evaluation of adherence to preventive treatment among child tuberculosis contacts in Indonesia.
    Int J Tuberc Lung Dis. 2016;20:1078-83.
    PubMed     Text format     Abstract available


  170. MARITZ ER, Montepiedra G, Liu L, Mitchell CD, et al
    Source case identification in HIV-exposed infants and tuberculosis diagnosis in an isoniazid prevention study.
    Int J Tuberc Lung Dis. 2016;20:1060-4.
    PubMed     Text format     Abstract available


  171. ADJOBIMEY M, Masserey E, Adjonou C, Gbenagnon G, et al
    Implementation of isoniazid preventive therapy in children aged under 5 years exposed to tuberculosis in Benin.
    Int J Tuberc Lung Dis. 2016;20:1055-9.
    PubMed     Text format     Abstract available


  172. FLICK RJ, Kim MH, Simon K, Munthali A, et al
    Burden of disease and risk factors for death among children treated for tuberculosis in Malawi.
    Int J Tuberc Lung Dis. 2016;20:1046-54.
    PubMed     Text format     Abstract available


  173. BRENNAN AT, Bonawitz R, Schnippel K, Berhanu R, et al
    Incident tuberculosis in HIV-positive children, adolescents and adults on antiretroviral therapy in South Africa.
    Int J Tuberc Lung Dis. 2016;20:1040-5.
    PubMed     Text format     Abstract available


  174. HENOSTROZA G, Harris JB, Chitambi R, Siyambango M, et al
    High prevalence of tuberculosis in newly enrolled HIV patients in Zambia: need for enhanced screening approach.
    Int J Tuberc Lung Dis. 2016;20:1033-9.
    PubMed     Text format     Abstract available


  175. SOUSA P, Oliveira A, Gomes M, Gaio AR, et al
    Longitudinal clustering of tuberculosis incidence and predictors for the time profiles: the impact of HIV.
    Int J Tuberc Lung Dis. 2016;20:1027-32.
    PubMed     Text format     Abstract available


  176. SUBRAMANI R, Gomathy S, Lakshmi M, Swaminathan S, et al
    Trend in the incidence of smear-positive tuberculosis in a district in South India after DOTS implementation.
    Int J Tuberc Lung Dis. 2016;20:1022-6.
    PubMed     Text format     Abstract available


  177. SENKORO M, Mfinanga S, Egwaga S, Mtandu R, et al
    Prevalence of pulmonary tuberculosis in adult population of Tanzania: a national survey, 2012.
    Int J Tuberc Lung Dis. 2016;20:1014-21.
    PubMed     Text format     Abstract available


  178. SABIITI W, Mtafya B, Kuchaka D, Azam K, et al
    Optimising molecular diagnostic capacity for effective control of tuberculosis in high-burden settings.
    Int J Tuberc Lung Dis. 2016;20:1004-9.
    PubMed     Text format     Abstract available


  179. ANDRE E, Isaacs C, Affolabi D, Alagna R, et al
    Connectivity of diagnostic technologies: improving surveillance and accelerating tuberculosis elimination.
    Int J Tuberc Lung Dis. 2016;20:999-1003.
    PubMed     Text format     Abstract available


  180. HESSELING AC, Rabie H
    Tuberculosis and HIV remain major causes of death in African children.
    Int J Tuberc Lung Dis. 2016;20:996-7.
    PubMed     Text format    


    July 2016
  181. MAJUMDER A, Carroll B, Bhana S, Tefu D, et al
    Screening for active tuberculosis in a diabetes mellitus clinic in Soweto, South Africa.
    Int J Tuberc Lung Dis. 2016;20:992-3.
    PubMed     Text format    


  182. GERONA R, Wen A, Koss C, Bacchetti P, et al
    A multi-analyte panel for non-invasive pharmacokinetic monitoring of second-line anti-tuberculosis drugs.
    Int J Tuberc Lung Dis. 2016;20:991-2.
    PubMed     Text format    


  183. CASTRO JL
    In reply: The language of tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:989-90.
    PubMed     Text format    


  184. DESHMUKH R
    Targeting zero tuberculosis deaths among people living with HIV: a call for action.
    Int J Tuberc Lung Dis. 2016;20:988.
    PubMed     Text format    


  185. LESSEM E, Frick M
    Ensuring availability of the best tuberculosis treatment options in the Philippines.
    Int J Tuberc Lung Dis. 2016;20:988-9.
    PubMed     Text format    


  186. OH KH, Kim HJ, Kim MH
    Non-communicable diseases and risk of tuberculosis in Korea.
    Int J Tuberc Lung Dis. 2016;20:973-7.
    PubMed     Text format     Abstract available


  187. YIN XM, Wu LJ, Zheng L, Mao XR, et al
    Quantification of colony-forming units for M. tuberculosis complex using gyrB-based real-time PCR assay.
    Int J Tuberc Lung Dis. 2016;20:967-72.
    PubMed     Text format     Abstract available


  188. SHIN SS, Chang AH, Ghosh JK, Dube MP, et al
    Isoniazid therapy for Mycobacterium tuberculosis infection in HIV clinics, Los Angeles, California.
    Int J Tuberc Lung Dis. 2016;20:961-6.
    PubMed     Text format     Abstract available


  189. MAZE MJ, Paynter J, Chiu W, Hu R, et al
    Therapeutic drug monitoring of isoniazid and rifampicin during anti-tuberculosis treatment in Auckland, New Zealand.
    Int J Tuberc Lung Dis. 2016;20:955-60.
    PubMed     Text format     Abstract available


  190. CHOI H, Chung H, Muntaner C, Lee M, et al
    The impact of social conditions on patient adherence to pulmonary tuberculosis treatment.
    Int J Tuberc Lung Dis. 2016;20:948-54.
    PubMed     Text format     Abstract available


  191. CASTRO KG, Marks SM, Chen MP, Hill AN, et al
    Estimating tuberculosis cases and their economic costs averted in the United States over the past two decades.
    Int J Tuberc Lung Dis. 2016;20:926-33.
    PubMed     Text format     Abstract available


  192. IBARZ-PAVON AB, Papaventsis D, Kalkouni R, Metaxas G, et al
    Pilot study of the completeness of notification of adult tuberculosis in Athens, Greece.
    Int J Tuberc Lung Dis. 2016;20:920-5.
    PubMed     Text format     Abstract available


  193. PAVLINAC PB, Lokken EM, Walson JL, Richardson BA, et al
    Mycobacterium tuberculosis bacteremia in adults and children: a systematic review and meta-analysis.
    Int J Tuberc Lung Dis. 2016;20:895-902.
    PubMed     Text format     Abstract available


  194. BARES R, Khalid N, Daniel H, Dittmann H, et al
    Hypothyroidism during second-line treatment of multidrug-resistant tuberculosis: a prospective study.
    Int J Tuberc Lung Dis. 2016;20:876-81.
    PubMed     Text format     Abstract available


  195. STAGG HR, Hatherell HA, Lipman MC, Harris RJ, et al
    Treatment regimens for rifampicin-resistant tuberculosis: highlighting a research gap.
    Int J Tuberc Lung Dis. 2016;20:866-9.
    PubMed     Text format     Abstract available


  196. DEAN AS, Zignol M, Lumb R, Lalor M, et al
    Sputum smear microscopy result: a predictor for drug-resistant tuberculosis?
    Int J Tuberc Lung Dis. 2016;20:864-5.
    PubMed     Text format     Abstract available


  197. KOETHE JR, von Reyn CF
    Protein-calorie malnutrition, macronutrient supplements, and tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:857-63.
    PubMed     Text format     Abstract available


    June 2016
  198. BALCELLS ME, Huilcaman M, Pena C, Castillo C, et al
    M. tuberculosis DNA detection in nasopharyngeal mucosa can precede tuberculosis development in contacts.
    Int J Tuberc Lung Dis. 2016;20:848-52.
    PubMed     Text format     Abstract available


  199. MAVE V, Chandanwale A, Kinikar A, Khadse S, et al
    Isoniazid hair concentrations in children with tuberculosis: a proof of concept study.
    Int J Tuberc Lung Dis. 2016;20:844-7.
    PubMed     Text format     Abstract available


  200. SINGH M, Sethi GR, Mantan M, Khanna A, et al
    Xpert((R)) MTB/RIF assay for the diagnosis of pulmonary tuberculosis in children.
    Int J Tuberc Lung Dis. 2016;20:839-43.
    PubMed     Text format     Abstract available


  201. JINDANI A, Borgulya G, de Patino IW, Gonzales T, et al
    A randomised Phase II trial to evaluate the toxicity of high-dose rifampicin to treat pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:832-8.
    PubMed     Text format     Abstract available


  202. HOLLAND DP, Hamilton CD, Stout JE
    Tackling the unknowns of short-course rifapentine-based treatment for active tuberculosis: a decision analysis.
    Int J Tuberc Lung Dis. 2016;20:827-31.
    PubMed     Text format     Abstract available


  203. MOTA L, Al-Efraij K, Campbell JR, Cook VJ, et al
    Therapeutic drug monitoring in anti-tuberculosis treatment: a systematic review and meta-analysis.
    Int J Tuberc Lung Dis. 2016;20:819-26.
    PubMed     Text format     Abstract available


  204. CHEN R, Wang J, Tang SW, Zhang Y, et al
    CYP7A1, BAAT and UGT1A1 polymorphisms and susceptibility to anti-tuberculosis drug-induced hepatotoxicity.
    Int J Tuberc Lung Dis. 2016;20:812-8.
    PubMed     Text format     Abstract available


  205. DHATWALIA SK, Yadav R, Behera D, Rudramurthy SM, et al
    Distribution and association of Mycobacterium tuberculosis CAS lineage with multidrug resistance in North India.
    Int J Tuberc Lung Dis. 2016;20:806-11.
    PubMed     Text format     Abstract available


  206. LEE SS, Lee CM, Kim TH, Kim JJ, et al
    Frequency and risk factors of drug-induced liver injury during treatment of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:800-5.
    PubMed     Text format     Abstract available


  207. SANDER MS, Vuchas CY, Numfor HN, Nsimen AN, et al
    Sputum bacterial load predicts multidrug-resistant tuberculosis in retreatment patients: a case-control study.
    Int J Tuberc Lung Dis. 2016;20:793-9.
    PubMed     Text format     Abstract available


  208. JENSENIUS M, Winje BA, Blomberg B, Mengshoel AT, et al
    Multidrug-resistant tuberculosis in Norway: a nationwide study, 1995-2014.
    Int J Tuberc Lung Dis. 2016;20:786-92.
    PubMed     Text format     Abstract available


  209. MACPHERSON P, Squire SB, Cleary P, Davies S, et al
    Equitable tuberculosis care in the North West of England: analysis of tuberculosis cohort review data.
    Int J Tuberc Lung Dis. 2016;20:778-85.
    PubMed     Text format     Abstract available


  210. CARAFFA E, Schepisi MS, Gualano G, Parracino MP, et al
    The diabetes-tuberculosis co-epidemic: the role of international migration.
    Int J Tuberc Lung Dis. 2016;20:771-7.
    PubMed     Text format     Abstract available


  211. CAMPBELL JR, Krot J, Marra F
    Latent tuberculosis diagnostic tests to predict longitudinal tuberculosis during dialysis: a meta-analysis.
    Int J Tuberc Lung Dis. 2016;20:764-70.
    PubMed     Text format     Abstract available


  212. EVERATT R, Kuzmickiene I, Davidaviciene E, Cicenas S, et al
    Incidence of lung cancer among patients with tuberculosis: a nationwide cohort study in Lithuania.
    Int J Tuberc Lung Dis. 2016;20:757-63.
    PubMed     Text format     Abstract available


  213. LEUNG CC
    Does tuberculosis increase the risk of lung cancer?
    Int J Tuberc Lung Dis. 2016;20:712.
    PubMed     Text format    


    May 2016
  214. BRANAGAN P, Moran B, Fitzgibbon M, Reid V, et al
    Inoculation site leprosy in a tattoo as a paradoxical reaction following tuberculosis treatment.
    Int J Tuberc Lung Dis. 2016;20:706-8.
    PubMed     Text format     Abstract available


  215. ARYANPUR M, Masjedi MR, Hosseini M, Mortaz E, et al
    Cigarette smoking in patients newly diagnosed with pulmonary tuberculosis in Iran.
    Int J Tuberc Lung Dis. 2016;20:679-84.
    PubMed     Text format     Abstract available


  216. YELLAPPA V, Battaglioli T, Gurum SK, Narayanan D, et al
    Private practitioners' contributions to the Revised National Tuberculosis Control Programme in a South Indian district.
    Int J Tuberc Lung Dis. 2016;20:659-65.
    PubMed     Text format     Abstract available


  217. GLOBAN M, Lavender C, Leslie D, Brown L, et al
    Molecular epidemiology of tuberculosis in Victoria, Australia, reveals low level of transmission.
    Int J Tuberc Lung Dis. 2016;20:652-8.
    PubMed     Text format     Abstract available


  218. GURBANOVA E, Mehdiyev R, Blondal K, Altraja A, et al
    Predictors of cure in rifampicin-resistant tuberculosis in prison settings with low loss to follow-up.
    Int J Tuberc Lung Dis. 2016;20:645-51.
    PubMed     Text format     Abstract available


  219. SEIFERT M, Ajbani K, Georghiou SB, Catanzaro D, et al
    A performance evaluation of MTBDRplus version 2 for the diagnosis of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:631-7.
    PubMed     Text format     Abstract available


  220. PINTO M, Steffen RE, Cobelens F, van den Hof S, et al
    Cost-effectiveness of the Xpert((R)) MTB/RIF assay for tuberculosis diagnosis in Brazil.
    Int J Tuberc Lung Dis. 2016;20:611-8.
    PubMed     Text format     Abstract available


  221. QUISPE R, Valle GA, Huapaya JA, Novoa I, et al
    Manual MGIT system for the detection of Mycobacterium tuberculosis: insights from a high TB burden setting.
    Int J Tuberc Lung Dis. 2016;20:605-10.
    PubMed     Text format     Abstract available


  222. JOHNSON MG, Stout JE, Benator DA, Whitworth WC, et al
    Medium matters: modeling the impact of solid medium performance on tuberculosis trial sample size requirements.
    Int J Tuberc Lung Dis. 2016;20:600-4.
    PubMed     Text format     Abstract available


  223. NAKAGGWA P, Odeke R, Kirenga BJ, Bloss E, et al
    Incomplete sputum smear microscopy monitoring among smear-positive tuberculosis patients in Uganda.
    Int J Tuberc Lung Dis. 2016;20:594-9.
    PubMed     Text format     Abstract available


  224. CHUCK C, Robinson E, Macaraig M, Alexander M, et al
    Enhancing management of tuberculosis treatment with video directly observed therapy in New York City.
    Int J Tuberc Lung Dis. 2016;20:588-93.
    PubMed     Text format     Abstract available


  225. NAGAVCI BL, de Gelder R, Martikainen P, Deboosere P, et al
    Inequalities in tuberculosis mortality: long-term trends in 11 European countries.
    Int J Tuberc Lung Dis. 2016;20:574-81.
    PubMed     Text format     Abstract available


  226. CHAULK CP, Belknap R
    A public heath 'selfie' for treating tuberculosis?
    Int J Tuberc Lung Dis. 2016;20:571.
    PubMed     Text format    


  227. VAN RIE A, Taylor R
    Can we translate findings on inequality in tuberculosis mortality into policy?
    Int J Tuberc Lung Dis. 2016;20:569-70.
    PubMed     Text format    


  228. NICOLINI A, Perazzo A, Gatto P, Piroddi IM, et al
    A rare adverse reaction to ethambutol: drug-induced haemolytic anaemia.
    Int J Tuberc Lung Dis. 2016;20:704-5.
    PubMed     Text format     Abstract available


  229. MUKHERJEE A, Velpandian T, Singla M, Kanhiya K, et al
    Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in HIV-infected Indian children.
    Int J Tuberc Lung Dis. 2016;20:666-72.
    PubMed     Text format     Abstract available


  230. RUAN YZ, Li RZ, Wang XX, Wang LX, et al
    The affordability for patients of a new universal MDR-TB coverage model in China.
    Int J Tuberc Lung Dis. 2016;20:638-44.
    PubMed     Text format     Abstract available


  231. MODI M, Sharma K, Sharma M, Sharma A, et al
    Multitargeted loop-mediated isothermal amplification for rapid diagnosis of tuberculous meningitis.
    Int J Tuberc Lung Dis. 2016;20:625-30.
    PubMed     Text format     Abstract available


  232. MOK Y, Tan TY, Tay TR, Wong HS, et al
    Do we need transbronchial lung biopsy if we have bronchoalveolar lavage Xpert(R) MTB/RIF?
    Int J Tuberc Lung Dis. 2016;20:619-24.
    PubMed     Text format     Abstract available


    April 2016
  233. BRONNER MURRISON L, Ananthakrishnan R, Swaminathan A, Auguesteen S, et al
    How do patients access the private sector in Chennai, India? An evaluation of delays in tuberculosis diagnosis.
    Int J Tuberc Lung Dis. 2016;20:544-51.
    PubMed     Text format     Abstract available


  234. MCDOWELL A, Pai M
    Treatment as diagnosis and diagnosis as treatment: empirical management of presumptive tuberculosis in India.
    Int J Tuberc Lung Dis. 2016;20:536-43.
    PubMed     Text format     Abstract available


  235. CALDERON HERNAIZ R, Ruiz Giardin JM, Cabello Clotet N, Canora Lebrato J, et al
    Tuberculosis and immigration in an area of southwest Madrid.
    Int J Tuberc Lung Dis. 2016;20:530-5.
    PubMed     Text format     Abstract available


  236. KIM S, Kim H, Kim WJ, Lee SJ, et al
    Mortality and predictors in pulmonary tuberculosis with respiratory failure requiring mechanical ventilation.
    Int J Tuberc Lung Dis. 2016;20:524-9.
    PubMed     Text format     Abstract available


  237. DALE K, Tay E, Trevan P, Denholm JT, et al
    Mortality among tuberculosis cases in Victoria, 2002-2013: case fatality and factors associated with death.
    Int J Tuberc Lung Dis. 2016;20:515-23.
    PubMed     Text format     Abstract available


  238. KANAMORI H, Hatakeyama T, Uchiyama B, Weber DJ, et al
    Clinical and molecular epidemiological features of tuberculosis after the 2011 Japan earthquake and tsunami.
    Int J Tuberc Lung Dis. 2016;20:505-14.
    PubMed     Text format     Abstract available


  239. SWAMINATHAN A, du Cros P, Seddon JA, Quinnell S, et al
    Treating children for drug-resistant tuberculosis in Tajikistan with Group 5 medications.
    Int J Tuberc Lung Dis. 2016;20:474-8.
    PubMed     Text format     Abstract available


  240. HUANG ZK, Luo Q, Qing C, Deng YT, et al
    Evaluation of the direct nitrate reductase assay for rapid detection of extensively drug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:468-73.
    PubMed     Text format     Abstract available


  241. LI H, Zhou LP, Luo J, Yu JP, et al
    Rapid colorimetric pyrazinamide susceptibility testing of Mycobacterium tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:462-7.
    PubMed     Text format     Abstract available


  242. ZHENG LH, Jia HY, Liu XJ, Sun HS, et al
    Modified cytospin slide microscopy method for rapid diagnosis of smear-negative pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:456-61.
    PubMed     Text format     Abstract available


  243. TAHSEEN S, Qadeer E, Khanzada FM, Rizvi AH, et al
    Use of Xpert((R)) MTB/RIF assay in the first national anti-tuberculosis drug resistance survey in Pakistan.
    Int J Tuberc Lung Dis. 2016;20:448-55.
    PubMed     Text format     Abstract available


  244. MARKS SM, Hirsch-Moverman Y, Salcedo K, Graviss EA, et al
    Characteristics and costs of multidrug-resistant tuberculosis in-patient care in the United States, 2005-2007.
    Int J Tuberc Lung Dis. 2016;20:435-41.
    PubMed     Text format     Abstract available


  245. O'DONNELL MR, Daftary A, Frick M, Hirsch-Moverman Y, et al
    Re-inventing adherence: toward a patient-centered model of care for drug-resistant tuberculosis and HIV.
    Int J Tuberc Lung Dis. 2016;20:430-4.
    PubMed     Text format     Abstract available


  246. SOTGIU G, Migliori GB
    TB-related mortality: a re-emerging problem in high-income countries?
    Int J Tuberc Lung Dis. 2016;20:428.
    PubMed     Text format    


  247. BILLO NE
    Costs for TB and MDR-TB: time to convene a WHO Emergency Committee on TB?
    Int J Tuberc Lung Dis. 2016;20:427.
    PubMed     Text format    


  248. BANDA H, Robinson R, Thomson R, Squire SB, et al
    The 'Practical Approach to Lung Health' in sub-Saharan Africa: a systematic review.
    Int J Tuberc Lung Dis. 2016;20:552-9.
    PubMed     Text format     Abstract available


  249. YU J, Wang ZJ, Chen LH, Li HH, et al
    Diagnostic accuracy of interferon-gamma release assays for tuberculous meningitis: a meta-analysis.
    Int J Tuberc Lung Dis. 2016;20:494-9.
    PubMed     Text format     Abstract available


  250. WANG F, Hou HY, Wu SJ, Zhu Q, et al
    Using the TBAg/PHA ratio in the T-SPOT((R)).TB assay to distinguish TB disease from LTBI in an endemic area.
    Int J Tuberc Lung Dis. 2016;20:487-93.
    PubMed     Text format     Abstract available


  251. SILVA AP, Hill P, Belo MT, Rabelo SG, et al
    Non-completion of latent tuberculous infection treatment among children in Rio de Janeiro State, Brazil.
    Int J Tuberc Lung Dis. 2016;20:479-86.
    PubMed     Text format     Abstract available


  252. KELLY AM, Smith B, Luo Z, Given B, et al
    Discordance between patient and clinician reports of adverse reactions to MDR-TB treatment.
    Int J Tuberc Lung Dis. 2016;20:442-7.
    PubMed     Text format     Abstract available


    March 2016
  253. SHIN SS, Modongo C, Zetola NM
    The impact of mixed infections on the interpretation of molecular epidemiology studies of tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:423-4.
    PubMed     Text format    


  254. SARIN P, Duffy J, Mughal Z, Hedayat E, et al
    Vitamin D and tuberculosis: review and association in three rural provinces of Afghanistan.
    Int J Tuberc Lung Dis. 2016;20:383-8.
    PubMed     Text format     Abstract available


  255. LO HY, Yang SL, Lin HH, Bai KJ, et al
    Does enhanced diabetes management reduce the risk and improve the outcome of tuberculosis?
    Int J Tuberc Lung Dis. 2016;20:376-82.
    PubMed     Text format     Abstract available


  256. PARR JB, Rich ML, Keshavjee S, Franke MF, et al
    Presumptive treatment of multidrug-resistant tuberculosis in household contacts.
    Int J Tuberc Lung Dis. 2016;20:370-5.
    PubMed     Text format     Abstract available


  257. QIN F, Barry PM, Pascopella L
    Factors associated with extended treatment among tuberculosis patients at risk of relapse in California.
    Int J Tuberc Lung Dis. 2016;20:363-9.
    PubMed     Text format     Abstract available


  258. PAULINO J, Martins A, Machado M, Gomes M, et al
    Tuberculosis in native- and foreign-born populations in Portugal.
    Int J Tuberc Lung Dis. 2016;20:357-62.
    PubMed     Text format     Abstract available


  259. SMITH A, Burger R, Claassens M, Ayles H, et al
    Health care workers' gender bias in testing could contribute to missed tuberculosis among women in South Africa.
    Int J Tuberc Lung Dis. 2016;20:350-6.
    PubMed     Text format     Abstract available


  260. KHAN PY, Glynn JR, Fielding KL, Mzembe T, et al
    Risk factors for Mycobacterium tuberculosis infection in 2-4 year olds in a rural HIV-prevalent setting.
    Int J Tuberc Lung Dis. 2016;20:342-9.
    PubMed     Text format     Abstract available


  261. YU X, Ma YF, Jiang GL, Chen ST, et al
    Sensititre(R) MYCOTB MIC plate for drug susceptibility testing of Mycobacterium tuberculosis complex isolates.
    Int J Tuberc Lung Dis. 2016;20:329-34.
    PubMed     Text format     Abstract available


  262. ZHANG T, Lv CF, Wang J, Zheng WB, et al
    Direct tuberculosis drug susceptibility testing: time-saving and cost-effective in detecting MDR-TB.
    Int J Tuberc Lung Dis. 2016;20:323-8.
    PubMed     Text format     Abstract available


  263. HO J, Nguyen PT, Nguyen TA, Tran HK, et al
    The role of macroscopic sputum quality assessments to optimise sputum testing for tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:319-22.
    PubMed     Text format     Abstract available


  264. HALIM KS, Islam MZ, Fatema N, Khan MD, et al
    Validation of smear-positive tuberculosis diagnoses in Bangladesh.
    Int J Tuberc Lung Dis. 2016;20:314-8.
    PubMed     Text format     Abstract available


  265. MAHESHWARI P, Chauhan K, Kadam R, Pujani A, et al
    Market assessment of tuberculosis diagnostics in India in 2013.
    Int J Tuberc Lung Dis. 2016;20:304-13.
    PubMed     Text format     Abstract available


  266. ZHAO YL, Pang Y, Xia H, Du X, et al
    Market assessment of tuberculosis diagnostics in China in 2012.
    Int J Tuberc Lung Dis. 2016;20:295-303.
    PubMed     Text format     Abstract available


  267. FURIN J, Alirol E, Allen E, Fielding K, et al
    Drug-resistant tuberculosis clinical trials: proposed core research definitions in adults.
    Int J Tuberc Lung Dis. 2016;20:290-4.
    PubMed     Text format     Abstract available


  268. KAPUR A
    Tuberculosis prevention and control: we need to pay heed to diabetes care.
    Int J Tuberc Lung Dis. 2016;20:287.
    PubMed     Text format    


  269. ZUMLA A, Davies PD
    Progress towards achieving global tuberculosis control: so near, yet so far.
    Int J Tuberc Lung Dis. 2016;20:285-6.
    PubMed     Text format    


  270. KOSGEI RJ, Sitienei JK, Kipruto H, Kimenye K, et al
    In reply.
    Int J Tuberc Lung Dis. 2016;20:425-6.
    PubMed     Text format    


  271. HORTON KC, Houben RM, White RG, Corbett EL, et al
    Time for men to count, too.
    Int J Tuberc Lung Dis. 2016;20:425.
    PubMed     Text format    


  272. COWAN J, Michel C, Manhica I, Mutaquiha C, et al
    Remote monitoring of Xpert(R) MTB/RIF testing in Mozambique: results of programmatic implementation of GxAlert.
    Int J Tuberc Lung Dis. 2016;20:335-41.
    PubMed     Text format     Abstract available


    February 2016
  273. SHARMA S, Nahar U, Das A, Radotra B, et al
    Acute respiratory distress syndrome in disseminated tuberculosis: an uncommon association.
    Int J Tuberc Lung Dis. 2016;20:271-5.
    PubMed     Text format     Abstract available


  274. FAN WC, Ou SM, Feng JY, Hu YW, et al
    Increased risk of pulmonary tuberculosis in patients with gastroesophageal reflux disease.
    Int J Tuberc Lung Dis. 2016;20:265-70.
    PubMed     Text format     Abstract available


  275. ZWERLING A, Gomez GB, Pennington J, Cobelens F, et al
    A simplified cost-effectiveness model to guide decision-making for shortened anti-tuberculosis treatment regimens.
    Int J Tuberc Lung Dis. 2016;20:257-60.
    PubMed     Text format     Abstract available


  276. CHANDRA TJ, Selvaraj R, Sharma YV
    Same-day sputum smear microscopy for the diagnosis of pulmonary tuberculosis: direct vs. concentrated smear.
    Int J Tuberc Lung Dis. 2016;20:247-51.
    PubMed     Text format     Abstract available


  277. JEENA L, Naidoo K
    Tuberculosis treatment outcomes among peri-urban children receiving doorstep tuberculosis care.
    Int J Tuberc Lung Dis. 2016;20:235-9.
    PubMed     Text format     Abstract available


  278. NGUYEN DT, Bang ND, Hung NQ, Beasley RP, et al
    Yield of chest radiograph in tuberculosis screening for HIV-infected persons at a district-level HIV clinic.
    Int J Tuberc Lung Dis. 2016;20:211-7.
    PubMed     Text format     Abstract available


  279. NLIWASA M, MacPherson P, Mukaka M, Mdolo A, et al
    High mortality and prevalence of HIV and tuberculosis in adults with chronic cough in Malawi: a cohort study.
    Int J Tuberc Lung Dis. 2016;20:202-10.
    PubMed     Text format     Abstract available


  280. HEYSELL SK, Ogarkov OB, Zhdanova S, Zorkaltseva E, et al
    Undertreated HIV and drug-resistant tuberculosis at a referral hospital in Irkutsk, Siberia.
    Int J Tuberc Lung Dis. 2016;20:187-92.
    PubMed     Text format     Abstract available


  281. LEW WJ, Harrington K, Garfin C, Islam T, et al
    Outcomes of Category I and II regimens in mono- and polyresistant tuberculosis cases in the Philippines.
    Int J Tuberc Lung Dis. 2016;20:170-6.
    PubMed     Text format     Abstract available


  282. MAJUMDAR T, Bhattacharya S, Barman D, Bhoumik P, et al
    Detection of multidrug-resistant tuberculosis using MGIT(TM) and MAS-PCR in Tripura, India.
    Int J Tuberc Lung Dis. 2016;20:166-9.
    PubMed     Text format     Abstract available


  283. GEORGHIOU SB, Ajbani K, Rodrigues C, Rodwell TC, et al
    Performance of a pyrosequencing platform in diagnosing drug-resistant extra-pulmonary tuberculosis in India.
    Int J Tuberc Lung Dis. 2016;20:160-5.
    PubMed     Text format     Abstract available


  284. MILLAN-LOU MI, Olle-Goig JE, Tortola MT, Martin C, et al
    Mycobacterial diversity causing multi- and extensively drug-resistant tuberculosis in Djibouti, Horn of Africa.
    Int J Tuberc Lung Dis. 2016;20:150-3.
    PubMed     Text format     Abstract available


  285. BOYLES TH, Kengne AP
    A priori estimation of diagnostic thresholds could improve the reporting of diagnostic studies of tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:147-9.
    PubMed     Text format    


  286. MITNICK C, van den Hof S
    Using existing data to illustrate-and close-the gap in access to new anti-tuberculosis drugs.
    Int J Tuberc Lung Dis. 2016;20:145.
    PubMed     Text format    


  287. TAKIFF H, Alame-Emane AK, Pierre-Audigier C, Gicquel B, et al
    In reply.
    Int J Tuberc Lung Dis. 2016;20:282-3.
    PubMed     Text format    


  288. COBELENS F, Gebhard A, van den Hof S
    No evidence that pyrazinamide resistance is acquired after fluoroquinolone resistance.
    Int J Tuberc Lung Dis. 2016;20:282.
    PubMed     Text format    


  289. YANG HK, Park MJ, Lee JH, Lee CT, et al
    Incidence of toxic optic neuropathy with low-dose ethambutol.
    Int J Tuberc Lung Dis. 2016;20:261-4.
    PubMed     Text format     Abstract available


  290. SIDIQ Z, Hanif M, Chopra KK, Khanna A, et al
    Random blinded rechecking of AFB smears in a pilot project at an intermediate reference laboratory.
    Int J Tuberc Lung Dis. 2016;20:252-6.
    PubMed     Text format     Abstract available


  291. MBONZE NB, Tabala M, Wenzi LK, Bakoko B, et al
    Xpert((R)) MTB/RIF for smear-negative presumptive TB: impact on case notification in DR Congo.
    Int J Tuberc Lung Dis. 2016;20:240-6.
    PubMed     Text format     Abstract available


  292. SABI I, Kabyemera R, Mshana SE, Kidenya BR, et al
    Pulmonary TB bacteriologically confirmed by induced sputum among children at Bugando Medical Centre, Tanzania.
    Int J Tuberc Lung Dis. 2016;20:228-34.
    PubMed     Text format     Abstract available


  293. ELIAS D, Akuffo H, Abate E, Mekonnen Y, et al
    Risk of tuberculous infection in adolescents and adults in a rural community in Ethiopia.
    Int J Tuberc Lung Dis. 2016;20:218-22.
    PubMed     Text format     Abstract available


  294. KERKHOFF AD, Meintjes G, Opie J, Vogt M, et al
    Anaemia in patients with HIV-associated TB: relative contributions of anaemia of chronic disease and iron deficiency.
    Int J Tuberc Lung Dis. 2016;20:193-201.
    PubMed     Text format     Abstract available


  295. BONNET M, Bastard M, du Cros P, Khamraev A, et al
    Identification of patients who could benefit from bedaquiline or delamanid: a multisite MDR-TB cohort study.
    Int J Tuberc Lung Dis. 2016;20:177-86.
    PubMed     Text format     Abstract available


  296. NIKAM C, Patel R, Sadani M, Ajbani K, et al
    Redefining MTBDRplus test results: what do indeterminate results actually mean?
    Int J Tuberc Lung Dis. 2016;20:154-9.
    PubMed     Text format     Abstract available


  297. GLAZIOU P, Floyd K, Weil D, Raviglione M, et al
    TB deaths rank alongside HIV deaths as top infectious killer.
    Int J Tuberc Lung Dis. 2016;20:143-4.
    PubMed     Text format    


    January 2016
  298. YANG PL, He XJ, Zang QJ, Li HP, et al
    Association of human leukocyte antigen DRB1 polymorphism and tuberculosis: a meta-analysis.
    Int J Tuberc Lung Dis. 2016;20:121-8.
    PubMed     Text format     Abstract available


  299. WATANABE A, Matsumoto T, Igari H, Sawa J, et al
    Risk of developing active tuberculosis in rheumatoid arthritis patients on adalimumab in Japan.
    Int J Tuberc Lung Dis. 2016;20:101-8.
    PubMed     Text format     Abstract available


  300. BURMEN B, Modi S, Cavanaugh JS, Muttai H, et al
    Tuberculosis screening outcomes for newly diagnosed persons living with HIV, Nyanza Province, Kenya, 2009.
    Int J Tuberc Lung Dis. 2016;20:79-84.
    PubMed     Text format     Abstract available


  301. AGUILERA XP, Gonzalez C, Najera-De Ferrari M, Hirmas M, et al
    Tuberculosis in prisoners and their contacts in Chile: estimating incidence and latent infection.
    Int J Tuberc Lung Dis. 2016;20:63-70.
    PubMed     Text format     Abstract available


  302. CHEN KS, Liu T, Lin RR, Peng YP, et al
    Tuberculosis transmission and risk factors in a Chinese antimony mining community.
    Int J Tuberc Lung Dis. 2016;20:57-62.
    PubMed     Text format     Abstract available


  303. KIM L, Moonan PK, Heilig CM, Woodruff RS, et al
    Factors associated with recurrent tuberculosis more than 12 months after treatment completion.
    Int J Tuberc Lung Dis. 2016;20:49-56.
    PubMed     Text format     Abstract available


  304. SHULDINER J, Leventhal A, Chemtob D, Mor Z, et al
    Mortality after anti-tuberculosis treatment completion: results of long-term follow-up.
    Int J Tuberc Lung Dis. 2016;20:43-8.
    PubMed     Text format     Abstract available


  305. DOMINGUEZ J, Boettger EC, Cirillo D, Cobelens F, et al
    Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a TBNET/RESIST-TB consensus statement.
    Int J Tuberc Lung Dis. 2016;20:24-42.
    PubMed     Text format     Abstract available


  306. YATES TA, Tanser F, Abubakar I
    Plan Beta for tuberculosis: it's time to think seriously about poorly ventilated congregate settings.
    Int J Tuberc Lung Dis. 2016;20:5-10.
    PubMed     Text format     Abstract available


  307. SOTGIU G, Centis R, Migliori GB
    Tuberculosis management and determinants of recurrence.
    Int J Tuberc Lung Dis. 2016;20:3.
    PubMed     Text format    


  308. VAN DEN HOF S, Borgdorff MW
    Elevated mortality after successful tuberculosis treatment.
    Int J Tuberc Lung Dis. 2016;20:2.
    PubMed     Text format    


  309. KO Y, Lee HK, Lee YS, Kim MY, et al
    Accuracy of Xpert((R)) MTB/RIF assay compared with AdvanSure TB/NTM real-time PCR using bronchoscopy specimens.
    Int J Tuberc Lung Dis. 2016;20:115-20.
    PubMed     Text format     Abstract available


  310. BENERI CA, Aaron L, Kim S, Jean-Philippe P, et al
    Understanding NIH clinical case definitions for pediatric intrathoracic TB by applying them to a clinical trial.
    Int J Tuberc Lung Dis. 2016;20:93-100.
    PubMed     Text format     Abstract available


  311. KAPOOR S, Gupta A, Shah M
    Cost-effectiveness of isoniazid preventive therapy for HIV-infected pregnant women in India.
    Int J Tuberc Lung Dis. 2016;20:85-92.
    PubMed     Text format     Abstract available


  312. HENSEL RL, Kempker RR, Tapia J, Oladele A, et al
    Increased risk of latent tuberculous infection among persons with pre-diabetes and diabetes mellitus.
    Int J Tuberc Lung Dis. 2016;20:71-8.
    PubMed     Text format     Abstract available


    December 2015
  313. MURRAY S, McKenna L, Pelfrene E, Botgros R, et al
    Accelerating clinical drug development for children with tuberculosis.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:69-74.
    PubMed     Text format     Abstract available


  314. TANEJA R, Garcia-Prats AJ, Furin J, Maheshwari HK, et al
    Paediatric formulations of second-line anti-tuberculosis medications: challenges and considerations.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:61-8.
    PubMed     Text format     Abstract available


  315. FURIN J, Mafukidze A, Brigden G, du Cros P, et al
    A bitter pill to swallow: the need for better medications for drug-resistant tuberculosis in children.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:55-60.
    PubMed     Text format     Abstract available


  316. BASSYOUNI H, Breugelmans JG, Surette M, Olesen O, et al
    Childhood tuberculosis: a unified response to a global problem.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:54.
    PubMed     Text format    


  317. CRUZ AT, Martinez BJ
    Childhood tuberculosis in the United States: shifting the focus to prevention.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:50-3.
    PubMed     Text format     Abstract available


  318. AMANULLAH F, Malik AA
    Unmasking childhood tuberculosis in Pakistan: efforts to improve detection and management.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:47-9.
    PubMed     Text format     Abstract available


  319. SWAMINATHAN S, Sachdeva KS
    Treatment of childhood tuberculosis in India.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:43-6.
    PubMed     Text format     Abstract available


  320. MALECHE-OBIMBO E, Wanjau W, Kathure I
    The journey to improve the prevention and management of childhood tuberculosis: the Kenyan experience.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:39-42.
    PubMed     Text format     Abstract available


  321. MALHOTRA S, Ursu I, Ghoneim R, Jodrey PP, et al
    From availability to uptake: planning for the introduction of new, child-friendly anti-tuberculosis formulations.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:32-8.
    PubMed     Text format     Abstract available


  322. USHERENKO I, Basu Roy U, Mazlish S, Liu S, et al
    Pediatric tuberculosis drug market: an insider perspective on challenges and solutions.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:23-31.
    PubMed     Text format     Abstract available


  323. SCOTT C, Gardiner E, de Lucia A
    The procurement landscape of pediatric tuberculosis treatment: a Global Drug Facility perspective.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:17-22.
    PubMed     Text format     Abstract available


  324. SEDDON JA, Jenkins HE, Liu L, Cohen T, et al
    Counting children with tuberculosis: why numbers matter.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:9-16.
    PubMed     Text format     Abstract available


  325. GRAHAM SM, Grzemska M, Gie RP
    The background and rationale for a new fixed-dose combination for first-line treatment of tuberculosis in children.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:3-8.
    PubMed     Text format     Abstract available


  326. GOOSBY E
    Out of the shadows: shining a light on children with tuberculosis.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:1-2.
    PubMed     Text format    


  327. LAWN SD, Kerkhoff AD
    Rapid diagnosis of TB in HIV-positive in-patients with M. tuberculosis bacteraemia in sub-Saharan Africa.
    Int J Tuberc Lung Dis. 2015;19:1557-9.
    PubMed     Text format    


  328. O'CONNOR BD, Woltmann G, Patel H, Turapov O, et al
    Can resuscitation-promoting factors be used to improve culture rates of extra-pulmonary tuberculosis?
    Int J Tuberc Lung Dis. 2015;19:1556-7.
    PubMed     Text format    


  329. REINA S, Silva C, Gaio AR, Correia AM, et al
    HIV screening in tuberculosis patients in the northern region of Portugal.
    Int J Tuberc Lung Dis. 2015;19:1554-5.
    PubMed     Text format    


  330. ARDIZZONI E, Mulders W, Kotrikadze T, Aspindzelashvili R, et al
    The thin-layer agar method for direct phenotypic detection of multi- and extensively drug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:1547-52.
    PubMed     Text format     Abstract available


  331. CAUSSE M, Ruiz P, Gutierrez JB, Vaquero M, et al
    New Anyplex II MTB/MDR/XDR kit for detection of resistance mutations in M. tuberculosis cultures.
    Int J Tuberc Lung Dis. 2015;19:1542-6.
    PubMed     Text format     Abstract available


  332. MALHOTRA B, Goyal S, Bhargava S, Reddy PV, et al
    Rapid detection of rifampicin resistance in Mycobacterium tuberculosis by high-resolution melting curve analysis.
    Int J Tuberc Lung Dis. 2015;19:1536-41.
    PubMed     Text format     Abstract available


  333. LORENT N, Kong C, Kim T, Sam S, et al
    Systematic screening for drug-resistant tuberculosis with Xpert((R)) MTB/RIF in a referral hospital in Cambodia.
    Int J Tuberc Lung Dis. 2015;19:1528-35.
    PubMed     Text format     Abstract available


  334. GUNTHER G, van Leth F, Altet N, Dedicoat M, et al
    Beyond multidrug-resistant tuberculosis in Europe: a TBNET study.
    Int J Tuberc Lung Dis. 2015;19:1524-7.
    PubMed     Text format     Abstract available


  335. CRUDU V, Merker M, Lange C, Noroc E, et al
    Nosocomial transmission of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:1520-3.
    PubMed     Text format     Abstract available


  336. RAMMA L, Cox H, Wilkinson L, Foster N, et al
    Patients' costs associated with seeking and accessing treatment for drug-resistant tuberculosis in South Africa.
    Int J Tuberc Lung Dis. 2015;19:1513-9.
    PubMed     Text format     Abstract available


  337. MORENO-MARTINEZ A, Casals M, Orcau A, Gorrindo P, et al
    Factors associated with diabetes mellitus among adults with tuberculosis in a large European city, 2000-2013.
    Int J Tuberc Lung Dis. 2015;19:1507-12.
    PubMed     Text format     Abstract available


  338. LU MC, Lai CL, Tsai CC, Koo M, et al
    Increased risk of pulmonary and extra-pulmonary tuberculosis in patients with rheumatic diseases.
    Int J Tuberc Lung Dis. 2015;19:1500-6.
    PubMed     Text format     Abstract available


  339. AL-EFRAIJ K, Mota L, Lunny C, Schachter M, et al
    Risk of active tuberculosis in chronic kidney disease: a systematic review and meta-analysis.
    Int J Tuberc Lung Dis. 2015;19:1493-9.
    PubMed     Text format     Abstract available


  340. PAGAOA MA, Royce RA, Chen MP, Golub JE, et al
    Risk factors for transmission of tuberculosis among United States-born African Americans and Whites.
    Int J Tuberc Lung Dis. 2015;19:1485-92.
    PubMed     Text format     Abstract available


  341. CHUNG W, Lee K, Jung Y, Kim Y, et al
    Serum CXCR3 ligands as biomarkers for the diagnosis and treatment monitoring of tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:1476-84.
    PubMed     Text format     Abstract available


  342. AMANATIDOU V, Critselis E, Trochoutsou A, Soldatou A, et al
    Interferon gamma inducible protein-10 in the diagnosis of paediatric tuberculosis infection in a low TB incidence country.
    Int J Tuberc Lung Dis. 2015;19:1463-9.
    PubMed     Text format     Abstract available


  343. LU TT, Lin XQ, Zhang L, Cai W, et al
    Magnetic resonance angiography manifestations and prognostic significance in HIV-negative tuberculosis meningitis.
    Int J Tuberc Lung Dis. 2015;19:1448-54.
    PubMed     Text format     Abstract available


  344. WANG Y, Wu JP, Qin GC, Li DY, et al
    Computerised tomography and intravenous pyelography in urinary tuberculosis: a retrospective descriptive study.
    Int J Tuberc Lung Dis. 2015;19:1441-7.
    PubMed     Text format     Abstract available


  345. ALLWOOD BW, Goldin J, Said-Hartley Q, van Zyl-Smit RN, et al
    Assessment of previous tuberculosis status using questionnaires, chest X-rays and computed tomography scans.
    Int J Tuberc Lung Dis. 2015;19:1435-40.
    PubMed     Text format     Abstract available


  346. TRIASIH R, Robertson C, de Campo J, Duke T, et al
    An evaluation of chest X-ray in the context of community-based screening of child tuberculosis contacts.
    Int J Tuberc Lung Dis. 2015;19:1428-34.
    PubMed     Text format     Abstract available


  347. CHANG KC, Yew WW, Sotgiu G
    Clinical research in the treatment of tuberculosis: current status and future prospects.
    Int J Tuberc Lung Dis. 2015;19:1417-27.
    PubMed     Text format     Abstract available


  348. COURTENAY-QUIRK C, Date A, Bachanas P, Baggaley R, et al
    Expanding human immunodeficiency virus testing and counseling to reach tuberculosis clients' partners and families.
    Int J Tuberc Lung Dis. 2015;19:1414-6.
    PubMed     Text format     Abstract available


  349. STOUT JE
    The cost of 'free' tuberculosis care.
    Int J Tuberc Lung Dis. 2015;19:1413.
    PubMed     Text format    


  350. OHKADO A
    How can we sensibly rule out previous episodes of pulmonary tuberculosis disease?
    Int J Tuberc Lung Dis. 2015;19:1412.
    PubMed     Text format    


    November 2015
  351. ABBARA A, Newsholme W, Klein JL, Chambers JB, et al
    Tuberculous endocarditis in an immunocompetent host without miliary tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:1407-8.
    PubMed     Text format    


  352. SHEN TC, Lin CL, Wei CC, Chen CH, et al
    Previous history of tuberculosis is associated with rheumatoid arthritis.
    Int J Tuberc Lung Dis. 2015;19:1401-5.
    PubMed     Text format     Abstract available


  353. YU SN, Cho OH, Park KH, Jung J, et al
    Late paradoxical lymph node enlargement during and after anti-tuberculosis treatment in non-HIV-infected patients.
    Int J Tuberc Lung Dis. 2015;19:1388-94.
    PubMed     Text format     Abstract available


  354. MANIKA K, Chatzika K, Papaioannou M, Kontou P, et al
    Rifampicin-moxifloxacin interaction in tuberculosis treatment: a real-life study.
    Int J Tuberc Lung Dis. 2015;19:1383-7.
    PubMed     Text format     Abstract available


  355. HATSUDA K, Takeuchi M, Ogata K, Sasaki Y, et al
    The impact of nutritional state on the duration of sputum positivity of Mycobacterium tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:1369-75.
    PubMed     Text format     Abstract available


  356. KRIEL M, Lotz JW, Kidd M, Walzl G, et al
    Evaluation of a radiological severity score to predict treatment outcome in adults with pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:1354-60.
    PubMed     Text format     Abstract available


  357. SHARMA A, Musau S, Heilig CM, Okumu AO, et al
    Assessing the effect of decentralisation of laboratory diagnosis for drug-resistant tuberculosis in Kenya.
    Int J Tuberc Lung Dis. 2015;19:1348-53.
    PubMed     Text format     Abstract available


  358. MARANGU D, Devine B, John-Stewart G
    Diagnostic accuracy of nucleic acid amplification tests in urine for pulmonary tuberculosis: a meta-analysis.
    Int J Tuberc Lung Dis. 2015;19:1339-47.
    PubMed     Text format     Abstract available


  359. COLVIN CJ, Leon N, Wills C, van Niekerk M, et al
    Global-to-local policy transfer in the introduction of new molecular tuberculosis diagnostics in South Africa.
    Int J Tuberc Lung Dis. 2015;19:1326-38.
    PubMed     Text format     Abstract available


  360. DOS SANTOS DIAS E, do Prado TN, da Silva Guimaraes AL, Ramos MC, et al
    Childhood tuberculosis and human immunodeficiency virus status in Brazil: a hierarchical analysis.
    Int J Tuberc Lung Dis. 2015;19:1305-11.
    PubMed     Text format     Abstract available


  361. KAWATSU L, Izumi K, Uchimura K, Urakawa M, et al
    Can social network analysis assist in the prioritisation of contacts in a tuberculosis contact investigation?
    Int J Tuberc Lung Dis. 2015;19:1293-9.
    PubMed     Text format     Abstract available


  362. ZHANG Y, Yew WW
    Mechanisms of drug resistance in Mycobacterium tuberculosis: update 2015.
    Int J Tuberc Lung Dis. 2015;19:1276-89.
    PubMed     Text format     Abstract available


  363. ZACHARIAH R, Ortuno N, Hermans V, Desalegn W, et al
    Ebola, fragile health systems and tuberculosis care: a call for pre-emptive action and operational research.
    Int J Tuberc Lung Dis. 2015;19:1271-5.
    PubMed     Text format     Abstract available


  364. SLOAN DJ, O'Dempsey TJ
    Tuberculosis in the time of Ebola: obstacles and opportunities.
    Int J Tuberc Lung Dis. 2015;19:1269.
    PubMed     Text format    


  365. TREBUCQ A, Devi S
    Widespread use of Xpert((R)) MTB/RIF will most probably reduce the total number of TB cases notified.
    Int J Tuberc Lung Dis. 2015;19:1406.
    PubMed     Text format    


  366. CRESWELL J, Rai B, Codlin AJ
    In reply.
    Int J Tuberc Lung Dis. 2015;19:1406-7.
    PubMed     Text format    


    October 2015
  367. VOLZ MS, Loddenkemper C, Morguet A, Moos V, et al
    Cardiac myxoma secreting interleukin-6 promotes cavitary tuberculosis: a case report.
    Int J Tuberc Lung Dis. 2015;19:1265-6.
    PubMed     Text format    


  368. NUNN AJ, Phillips PP, Abubakar I
    Reducing relapse in tuberculosis treatment.
    Int J Tuberc Lung Dis. 2015;19:1263-4.
    PubMed     Text format    


  369. GUPTA R, Geiter LJ, Hafkin J, Wells CD, et al
    Delamanid and QT prolongation in the treatment of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:1261-2.
    PubMed     Text format    


  370. PAINTER JA, Posey DL, Phares C
    Tuberculosis misclassification among immigrants.
    Int J Tuberc Lung Dis. 2015;19:1259-60.
    PubMed     Text format    


  371. DENHOLM JT, Matteelli A, Reis A
    In reply. Promoting ethical and evidence-based policies for latent tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:1258-9.
    PubMed     Text format    


  372. LI N, Xie WP, Kong H, Min R, et al
    Enrichment of regulatory T-cells in blood of patients with multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:1230-8.
    PubMed     Text format     Abstract available


  373. KAMBLI P, Ajbani K, Nikam C, Khillari A, et al
    Determination of MICs of levofloxacin for Mycobacterium tuberculosis with gyrA mutations.
    Int J Tuberc Lung Dis. 2015;19:1227-9.
    PubMed     Text format     Abstract available


  374. ELMARAACHLI W, Slater M, Berrada ZL, Lin SY, et al
    Predicting differential rifamycin resistance in clinical Mycobacterium tuberculosis isolates by specific rpoB mutations.
    Int J Tuberc Lung Dis. 2015;19:1222-6.
    PubMed     Text format     Abstract available


  375. KIM YW, Seong MW, Kim TS, Yoo CG, et al
    Evaluation of Xpert((R)) MTB/RIF assay: diagnosis and treatment outcomes in rifampicin-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:1216-21.
    PubMed     Text format     Abstract available


  376. TU HZ, Lin YE, Tseng MR, Huang TS, et al
    Cost-effective identification of Mycobacterium tuberculosis complex using microscopic morphology and rapid tests.
    Int J Tuberc Lung Dis. 2015;19:1204-8.
    PubMed     Text format     Abstract available


  377. ADELMAN MW, Tsegaye M, Kempker RR, Alebachew T, et al
    Intensified tuberculosis case finding among HIV-infected persons using a WHO symptom screen and Xpert((R)) MTB/RIF.
    Int J Tuberc Lung Dis. 2015;19:1197-203.
    PubMed     Text format     Abstract available


  378. REIS-SANTOS B, Pellacani-Posses I, Macedo LR, Golub JE, et al
    Directly observed therapy of tuberculosis in Brazil: associated determinants and impact on treatment outcome.
    Int J Tuberc Lung Dis. 2015;19:1188-93.
    PubMed     Text format     Abstract available


  379. VALENCA MS, Scaini JL, Abileira FS, Goncalves CV, et al
    Prevalence of tuberculosis in prisons: risk factors and molecular epidemiology.
    Int J Tuberc Lung Dis. 2015;19:1182-7.
    PubMed     Text format     Abstract available


  380. KOSGEI RJ, Sitienei JK, Kipruto H, Kimenye K, et al
    Gender differences in treatment outcomes among 15-49 year olds with smear-positive pulmonary tuberculosis in Kenya.
    Int J Tuberc Lung Dis. 2015;19:1176-81.
    PubMed     Text format     Abstract available


  381. KAMPER-JORGENSEN Z, Carstensen B, Norredam M, Bygbjerg IC, et al
    Diabetes-related tuberculosis in Denmark: effect of ethnicity, diabetes duration and year of diagnosis.
    Int J Tuberc Lung Dis. 2015;19:1169-75.
    PubMed     Text format     Abstract available


  382. SHIDAM UG, Roy G, Sahu SK, Kumar SV, et al
    Screening for diabetes among presumptive tuberculosis patients at a tertiary care centre in Pondicherry, India.
    Int J Tuberc Lung Dis. 2015;19:1163-8.
    PubMed     Text format     Abstract available


  383. MUKHERJEE A, Khandelwal D, Singla M, Lodha R, et al
    Outcomes of Category II anti-tuberculosis treatment in Indian children.
    Int J Tuberc Lung Dis. 2015;19:1153-7.
    PubMed     Text format     Abstract available


  384. CHIANG SS, Roche S, Contreras C, Alarcon V, et al
    Barriers to the diagnosis of childhood tuberculosis: a qualitative study.
    Int J Tuberc Lung Dis. 2015;19:1144-52.
    PubMed     Text format     Abstract available


  385. MASON PH, Degeling C, Denholm J
    Sociocultural dimensions of tuberculosis: an overview of key concepts.
    Int J Tuberc Lung Dis. 2015;19:1135-43.
    PubMed     Text format     Abstract available


  386. SOTGIU G, Matteelli A, Migliori GB
    Diabetes and tuberculosis: what else beyond?
    Int J Tuberc Lung Dis. 2015;19:1127-8.
    PubMed     Text format    


  387. STEVENSON DR, Biswas JR, Lievesley A, Quinn G, et al
    False-positive Xpert((R)) MTB/RIF more than seven years after cure.
    Int J Tuberc Lung Dis. 2015;19:1264-5.
    PubMed     Text format    


  388. EVANS TB, Mador MJ, Glick M
    In reply.
    Int J Tuberc Lung Dis. 2015;19:1260-1.
    PubMed     Text format    


  389. NOESKE J
    Sovereignty or dignity?
    Int J Tuberc Lung Dis. 2015;19:1258.
    PubMed     Text format    


  390. FURIN J, Harausz E, Zimetbaum P, Cox H, et al
    In reply. QTc prolongation and delamanid: access and safety.
    Int J Tuberc Lung Dis. 2015;19:1262-3.
    PubMed     Text format    


  391. JOHNSTON JC, Khan FA, Dowdy DW
    In reply.
    Int J Tuberc Lung Dis. 2015;19:1264.
    PubMed     Text format    


    September 2015
  392. ATRE S
    Notification of multidrug-resistant tuberculosis cases and treatment outcomes in the private sector.
    Int J Tuberc Lung Dis. 2015;19:1126.
    PubMed     Text format    


  393. RATNAPPULI A, Collinson S, Gaspar-Garcia E, Richardson L, et al
    Pott's disease in twenty-first century London: spinal tuberculosis as a continuing cause of morbidity and mortality.
    Int J Tuberc Lung Dis. 2015;19:1125-6.
    PubMed     Text format    


  394. SUEN SC, Bendavid E, Goldhaber-Fiebert JD
    Cost-effectiveness of improvements in diagnosis and treatment accessibility for tuberculosis control in India.
    Int J Tuberc Lung Dis. 2015;19:1115-24.
    PubMed     Text format     Abstract available


  395. CHOI Y, Hong SR, Jeon BY, Wang HY, et al
    Conventional and real-time PCR targeting 16S ribosomal RNA for the detection of Mycobacterium tuberculosis complex.
    Int J Tuberc Lung Dis. 2015;19:1102-8.
    PubMed     Text format     Abstract available


  396. HEO EY, Choi NK, Yang BR, Koo BK, et al
    Tuberculosis is frequently diagnosed within 12 months of diabetes mellitus.
    Int J Tuberc Lung Dis. 2015;19:1098-101.
    PubMed     Text format     Abstract available


  397. TOGUN TO, Egere U, Sillah AK, Ayorinde A, et al
    Contribution of Xpert((R)) MTB/RIF to the diagnosis of pulmonary tuberculosis among TB-exposed children in The Gambia.
    Int J Tuberc Lung Dis. 2015;19:1091-7.
    PubMed     Text format     Abstract available


  398. PAGE AL, Ardizzoni E, Lassovsky M, Kirubi B, et al
    Routine use of Xpert((R)) MTB/RIF in areas with different prevalences of HIV and drug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:1078-83.
    PubMed     Text format     Abstract available


  399. BASU I, Bower JE, Henderson GK, Lowe O, et al
    False-negative BD MGIT TBc Identification Test results in routine tuberculosis diagnosis: a New Zealand perspective.
    Int J Tuberc Lung Dis. 2015;19:1073-5.
    PubMed     Text format     Abstract available


  400. HERNANDEZ P, Punchak M, Camacho M, Hepple P, et al
    Investigating the quality of expectorated sputum for tuberculosis diagnosis in Bolivia.
    Int J Tuberc Lung Dis. 2015;19:1065-7.
    PubMed     Text format     Abstract available


  401. GARFEIN RS, Collins K, Munoz F, Moser K, et al
    Feasibility of tuberculosis treatment monitoring by video directly observed therapy: a binational pilot study.
    Int J Tuberc Lung Dis. 2015;19:1057-64.
    PubMed     Text format     Abstract available


  402. SITIENEI J, Kipruto H, Mansour O, Ndisha M, et al
    Correlates of default from anti-tuberculosis treatment: a case study using Kenya's electronic data system.
    Int J Tuberc Lung Dis. 2015;19:1051-6.
    PubMed     Text format     Abstract available


  403. SALYER SJ, Fitter DL, Milo R, Blanton C, et al
    Evaluation of the national tuberculosis surveillance program in Haiti.
    Int J Tuberc Lung Dis. 2015;19:1045-50.
    PubMed     Text format     Abstract available


  404. MORALES-GARCIA C, Parra-Ruiz J, Sanchez-Martinez JA, Delgado-Martin AE, et al
    Concomitant tuberculosis and lung cancer diagnosed by bronchoscopy.
    Int J Tuberc Lung Dis. 2015;19:1027-32.
    PubMed     Text format     Abstract available


  405. DEDICOAT M, Lange C
    Tuberculosis preventive chemotherapy: the times they are a-changin'.
    Int J Tuberc Lung Dis. 2015;19:1002.
    PubMed     Text format    


    August 2015
  406. REMASCHI G, Venturini E, Romano F, Perrone A, et al
    A rare cause of osteomyelitis with a rare genetic mutation: when Mycobacterium doesn't only mean tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:999-1000.
    PubMed     Text format    


  407. JOON D, Nimesh M, Saluja D
    Loop-mediated isothermal amplification as alternative to PCR for the diagnosis of extra-pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:986-91.
    PubMed     Text format     Abstract available


  408. NDJEKA N, Conradie F, Schnippel K, Hughes J, et al
    Treatment of drug-resistant tuberculosis with bedaquiline in a high HIV prevalence setting: an interim cohort analysis.
    Int J Tuberc Lung Dis. 2015;19:979-85.
    PubMed     Text format     Abstract available


  409. DU TOIT E, Squire SB, Dunbar R, Machekano R, et al
    Comparing multidrug-resistant tuberculosis patient costs under molecular diagnostic algorithms in South Africa.
    Int J Tuberc Lung Dis. 2015;19:960-8.
    PubMed     Text format     Abstract available


  410. ASANTE-POKU A, Otchere ID, Danso E, Mensah DD, et al
    Evaluation of GenoType((R)) MTBDRplus for the rapid detection of drug-resistant tuberculosis in Ghana.
    Int J Tuberc Lung Dis. 2015;19:954-9.
    PubMed     Text format     Abstract available


  411. HIRSCH-MOVERMAN Y, Cronin WA, Chen B, Moran JA, et al
    HIV counseling and testing in tuberculosis contact investigations in the United States and Canada.
    Int J Tuberc Lung Dis. 2015;19:943-53.
    PubMed     Text format     Abstract available


  412. LAI CC, Lee MT, Lee SH, Lee SH, et al
    Risk of incident active tuberculosis and use of corticosteroids.
    Int J Tuberc Lung Dis. 2015;19:936-42.
    PubMed     Text format     Abstract available


  413. KAWATSU L, Uchimura K, Kobayashi M, Ishikawa N, et al
    Overview of the tuberculosis burden in prison institutions in Japan, 2000-2012.
    Int J Tuberc Lung Dis. 2015;19:921-6.
    PubMed     Text format     Abstract available


  414. IWATA K, Doi A, Nakamura T, Yoshida H, et al
    The validity of three sputum smears taken in one day for discontinuing isolation of tuberculosis patients.
    Int J Tuberc Lung Dis. 2015;19:918-20.
    PubMed     Text format     Abstract available


  415. SHETE PB, Haguma P, Miller CR, Ochom E, et al
    Pathways and costs of care for patients with tuberculosis symptoms in rural Uganda.
    Int J Tuberc Lung Dis. 2015;19:912-7.
    PubMed     Text format     Abstract available


  416. SLOAN DJ, Mwandumba HC, Kamdolozi M, Shani D, et al
    Vitamin D deficiency in Malawian adults with pulmonary tuberculosis: risk factors and treatment outcomes.
    Int J Tuberc Lung Dis. 2015;19:904-11.
    PubMed     Text format     Abstract available


  417. JERENE D, Melese M, Kassie Y, Alem G, et al
    The yield of a tuberculosis household contact investigation in two regions of Ethiopia.
    Int J Tuberc Lung Dis. 2015;19:898-903.
    PubMed     Text format     Abstract available


  418. HARRIES AD, Kumar AM, Satyanarayana S, Lin Y, et al
    Diabetes mellitus and tuberculosis: programmatic management issues.
    Int J Tuberc Lung Dis. 2015;19:879-86.
    PubMed     Text format     Abstract available


  419. DAVIES PD, Martineau AR
    Vitamin D and tuberculosis: more effective in prevention than treatment?
    Int J Tuberc Lung Dis. 2015;19:876-7.
    PubMed     Text format    


  420. DAVIES PD
    Towards the elimination of tuberculosis and a reduction in chest diseases.
    Int J Tuberc Lung Dis. 2015;19:875.
    PubMed     Text format    


    July 2015
  421. VOLZ MS, Epple HJ, Schneider T
    Immune reconstitution inflammatory syndrome after BCG infection mimicking miliary tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:873-4.
    PubMed     Text format    


  422. BALAJEE KL, Rizwan SA, Kulkarni V, Silan V, et al
    Fixed-dose combination drugs for the treatment of tuberculosis under India's RNTCP.
    Int J Tuberc Lung Dis. 2015;19:870-1.
    PubMed     Text format    


  423. KOWADA A
    Cost-effectiveness of tobacco cessation support combined with tuberculosis screening among contacts who smoke.
    Int J Tuberc Lung Dis. 2015;19:857-63.
    PubMed     Text format     Abstract available


  424. ROBERTS-WITTEVEEN A, Reinten T, Christensen A, Sintchenko V, et al
    Multidrug-resistant tuberculosis in New South Wales, Australia, 1999-2010: a case series report.
    Int J Tuberc Lung Dis. 2015;19:850-6.
    PubMed     Text format     Abstract available


  425. LI CP, Zhou Y, Xiang X, Zhou Y, et al
    Relationship of HLA-DRB1 gene polymorphism with susceptibility to pulmonary tuberculosis: updated meta-analysis.
    Int J Tuberc Lung Dis. 2015;19:841-9.
    PubMed     Text format     Abstract available


  426. KAMUDUMULI PS, Beylis N, Blann L, Duse A, et al
    Molecular typing of drug-susceptible and -resistant Mycobacterium tuberculosis in Johannesburg, South Africa.
    Int J Tuberc Lung Dis. 2015;19:834-40.
    PubMed     Text format     Abstract available


  427. JUBULIS J, Dionne K, Osterhout G, Ayuk L, et al
    Mycobacterium tuberculosis resistance in pulmonary TB patients in Cameroon: a phenotypic susceptibility assay.
    Int J Tuberc Lung Dis. 2015;19:823-7.
    PubMed     Text format     Abstract available


  428. RIENTHONG S, Boonin C, Chaiyasirinrote B, Satproedprai N, et al
    Evaluation of a novel line-probe assay for genotyping-based diagnosis of Mycobacterium tuberculosis in Thailand.
    Int J Tuberc Lung Dis. 2015;19:817-22.
    PubMed     Text format     Abstract available


  429. DE LA MORA IL, Martinez-Oceguera D, Laniado-Laborin R
    Chronic airway obstruction after successful treatment of tuberculosis and its impact on quality of life.
    Int J Tuberc Lung Dis. 2015;19:808-10.
    PubMed     Text format     Abstract available


  430. HEMANTH KUMAR AK, Narendran G, Kumar RS, Ramachandran G, et al
    RMP exposure is lower in HIV-infected TB patients receiving intermittent than daily anti-tuberculosis treatment.
    Int J Tuberc Lung Dis. 2015;19:805-7.
    PubMed     Text format     Abstract available


  431. JONNALAGADDA S, LaCourse SM, Otieno P, Lohman-Payne B, et al
    Incidence and correlates of tuberculosis IGRA conversion among HIV-infected postpartum women.
    Int J Tuberc Lung Dis. 2015;19:792-8.
    PubMed     Text format     Abstract available


  432. ZHANG XL, Li SG, Li HT, Li GX, et al
    Integrating tuberculosis screening into annual health examinations for the rural elderly improves case detection.
    Int J Tuberc Lung Dis. 2015;19:787-91.
    PubMed     Text format     Abstract available


  433. DAWSON R, Narunsky K, Carman D, Gupte N, et al
    Two-stage activity-safety study of daily rifapentine during intensive phase treatment of pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:780-6.
    PubMed     Text format     Abstract available


  434. GAO Z, Parhar A, Gallant V, Heffernan C, et al
    A population-based study of tuberculosis case fatality in Canada: do Aboriginal peoples fare less well?
    Int J Tuberc Lung Dis. 2015;19:772-9.
    PubMed     Text format     Abstract available


  435. LIEW SM, Khoo EM, Ho BK, Lee YK, et al
    Tuberculosis in Malaysia: predictors of treatment outcomes in a national registry.
    Int J Tuberc Lung Dis. 2015;19:764-71.
    PubMed     Text format     Abstract available


  436. SATYANARAYANA S, Subbaraman R, Shete P, Gore G, et al
    Quality of tuberculosis care in India: a systematic review.
    Int J Tuberc Lung Dis. 2015;19:751-63.
    PubMed     Text format     Abstract available


  437. ADAMS CD, Velez JD, Martinez LF
    Xpert((R)) MTB/RIF and very low positive detection in bronchoalveolar lavage: diagnostic concerns.
    Int J Tuberc Lung Dis. 2015;19:871-3.
    PubMed     Text format    


  438. SIMONS SO, van der Laan T, de Zwaan R, Kamst M, et al
    Molecular drug susceptibility testing in the Netherlands: performance of the MTBDRplus and MTBDRsl assays.
    Int J Tuberc Lung Dis. 2015;19:828-33.
    PubMed     Text format     Abstract available


  439. HANRAHAN CF, Clouse K, Bassett J, Mutunga L, et al
    The patient impact of point-of-care vs. laboratory placement of Xpert((R)) MTB/RIF.
    Int J Tuberc Lung Dis. 2015;19:811-6.
    PubMed     Text format     Abstract available


  440. BISHARA H, Ore L, Vinitsky O, Bshara H, et al
    Cost of nurse-managed latent tuberculous infection treatment among hard-to-reach immigrants in Israel.
    Int J Tuberc Lung Dis. 2015;19:799-804.
    PubMed     Text format     Abstract available


    June 2015
  441. BABLISHVILI N, Tukvadze N, Avaliani Z, Blumberg HM, et al
    A comparison of the Xpert((R)) MTB/RIF and GenoType((R)) MTBDRplus assays in Georgia.
    Int J Tuberc Lung Dis. 2015;19:676-8.
    PubMed     Text format     Abstract available


  442. MCCARTHY KM, Scott LE, Gous N, Tellie M, et al
    High incidence of latent tuberculous infection among South African health workers: an urgent call for action.
    Int J Tuberc Lung Dis. 2015;19:647-53.
    PubMed     Text format     Abstract available


    May 2015
  443. RASHID ALI MR, Parameswaran U, William T, Bird E, et al
    A prospective study of mycobacterial viability in refrigerated, unpreserved sputum batched for up to 8 weeks.
    Int J Tuberc Lung Dis. 2015;19:620-1.
    PubMed     Text format    


  444. MUNN MS, Duchin JS, Kay M, Pecha M, et al
    Analysis of risk factors for tuberculous infection following exposure at a homeless shelter.
    Int J Tuberc Lung Dis. 2015;19:570-5.
    PubMed     Text format     Abstract available


  445. SUBEDI P, Drezner KA, Dogbey MC, Newbern EC, et al
    Evaluation of latent tuberculous infection and treatment completion for refugees in Philadelphia, PA, 2010-2012.
    Int J Tuberc Lung Dis. 2015;19:565-9.
    PubMed     Text format     Abstract available


  446. KUABAN C, Noeske J, Rieder HL, Ait-Khaled N, et al
    High effectiveness of a 12-month regimen for MDR-TB patients in Cameroon.
    Int J Tuberc Lung Dis. 2015;19:517-24.
    PubMed     Text format     Abstract available


  447. YEW WW, Chiang CY, Lumb R, Islam T, et al
    Are pulmonary non-tuberculous mycobacteria of concern in the Western Pacific Region?
    Int J Tuberc Lung Dis. 2015;19:499-500.
    PubMed     Text format    


    April 2015
  448. REVES RR
    In reply.
    Int J Tuberc Lung Dis. 2015;19:495.
    PubMed     Text format    


  449. BOYLES TH, Hughes J, Cox V, Burton R, et al
    False-positive Xpert((R)) MTB/RIF assays and previous treatment.
    Int J Tuberc Lung Dis. 2015;19:495-6.
    PubMed     Text format    


  450. PHILLIPS PP, Lipman MC
    Safe and effective treatment for patients with isoniazid drug resistance.
    Int J Tuberc Lung Dis. 2015;19:494-5.
    PubMed     Text format    


  451. ZELLWEGER JP, Bodmer T, Bischler U, Mykychak M, et al
    Implementation of the Stop TB strategy in a large TB hospital in Ukraine: achievements and deficiencies.
    Int J Tuberc Lung Dis. 2015;19:493-4.
    PubMed     Text format    


  452. HESSELING AC, Jaspan HB, Black GF, Nene N, et al
    Immunogenicity of BCG in HIV-exposed and non-exposed infants following routine birth or delayed vaccination.
    Int J Tuberc Lung Dis. 2015;19:454-62.
    PubMed     Text format     Abstract available


  453. KUMAR P, Kumar P, Balooni V, Singh S, et al
    Genetic mutations associated with rifampicin and isoniazid resistance in MDR-TB patients in North-West India.
    Int J Tuberc Lung Dis. 2015;19:434-9.
    PubMed     Text format     Abstract available


  454. VAN DEN HANDEL T, Hampton KH, Sanne I, Stevens W, et al
    The impact of Xpert((R)) MTB/RIF in sparsely populated rural settings.
    Int J Tuberc Lung Dis. 2015;19:392-8.
    PubMed     Text format     Abstract available


  455. YIM JJ, Koh WJ
    MDR-TB recurrence after successful treatment: additional studies using molecular genotyping are needed.
    Int J Tuberc Lung Dis. 2015;19:371.
    PubMed     Text format    


    March 2015
  456. STEINGART KR, Schiller I, Dendukuri N
    In reply to 'False-positive Xpert(R) MTB/RIF assays in previously treated patients'.
    Int J Tuberc Lung Dis. 2015;19:366-7.
    PubMed     Text format    


  457. HOGER S, Lykens K, Beavers S, Katz D, et al
    In reply.
    Int J Tuberc Lung Dis. 2015;19:367-8.
    PubMed     Text format    


  458. ZHANG H, Zhang JQ, Zhong XN, Liu GN, et al
    Two case reports of Castleman disease with pulmonary involvement.
    Int J Tuberc Lung Dis. 2015;19:362-5.
    PubMed     Text format     Abstract available


  459. PARK SJ, Jo KW, Yoo B, Lee CK, et al
    Comparison of LTBI treatment regimens for patients receiving anti-tumour necrosis factor therapy.
    Int J Tuberc Lung Dis. 2015;19:342-8.
    PubMed     Text format     Abstract available


  460. WANG HF, Wang R, O'Gorman M, Crownover P, et al
    Bioequivalence of fixed-dose combination RIN(R)-150 to each reference drug in loose combination.
    Int J Tuberc Lung Dis. 2015;19:333-8.
    PubMed     Text format     Abstract available


  461. MOYENGA I, Roggi A, Sulis G, Diande S, et al
    The impact of Xpert(R) MTB/RIF depends on service coordination: experience in Burkina Faso.
    Int J Tuberc Lung Dis. 2015;19:285-7.
    PubMed     Text format     Abstract available


  462. BOYLES TH, Thwaites GE
    Appropriate use of the Xpert(R) MTB/RIF assay in suspected tuberculous meningitis.
    Int J Tuberc Lung Dis. 2015;19:276-7.
    PubMed     Text format     Abstract available


  463. LIPPINCOTT CK, Miller MB, Van Rie A, Weber DJ, et al
    The complexities of Xpert(R) MTB/RIF interpretation.
    Int J Tuberc Lung Dis. 2015;19:273-5.
    PubMed     Text format     Abstract available


  464. RIEDER HL
    Jean-Antoine Villemin: ending an Alpine divide.
    Int J Tuberc Lung Dis. 2015;19:253.
    PubMed     Text format    


    February 2015
  465. SOLOMONS RS, Goussard P, Visser DH, Marais BJ, et al
    Chest radiograph findings in children with tuberculous meningitis.
    Int J Tuberc Lung Dis. 2015;19:200-4.
    PubMed     Text format     Abstract available


  466. LOVEDAY M, Wallengren K, Brust J, Roberts J, et al
    Community-based care vs. centralised hospitalisation for MDR-TB patients, KwaZulu-Natal, South Africa.
    Int J Tuberc Lung Dis. 2015;19:163-71.
    PubMed     Text format     Abstract available


  467. COLEMAN M, Finney LJ, Komrower D, Chitani A, et al
    Markers to differentiate between Kaposi's sarcoma and tuberculous pleural effusions in HIV-positive patients.
    Int J Tuberc Lung Dis. 2015;19:144-50.
    PubMed     Text format     Abstract available


  468. DENHOLM JT, Matteelli A, Reis A
    Latent tuberculous infection: ethical considerations in formulating public health policy.
    Int J Tuberc Lung Dis. 2015;19:137-40.
    PubMed     Text format     Abstract available


    January 2015
  469. ZISHIRI V, Chihota V, McCarthy K, Charalambous S, et al
    Pooling sputum from multiple individuals for Xpert(R) MTB/RIF testing: a strategy for screening high-risk populations.
    Int J Tuberc Lung Dis. 2015;19:87-90.
    PubMed     Text format     Abstract available


  470. SOLOMONS RS, Visser DH, Friedrich SO, Diacon AH, et al
    Improved diagnosis of childhood tuberculous meningitis using more than one nucleic acid amplification test.
    Int J Tuberc Lung Dis. 2015;19:74-80.
    PubMed     Text format     Abstract available


  471. YUEN CM, Krapivina TM, Kazennyy BY, Kiryanova EV, et al
    Annual risk of tuberculous infection measured using serial skin testing, Orel Oblast, Russia, 1991-2005.
    Int J Tuberc Lung Dis. 2015;19:39-43.
    PubMed     Text format     Abstract available


  472. HIRSCH-MOVERMAN Y, Shrestha-Kuwahara R, Bethel J, Blumberg HM, et al
    Latent tuberculous infection in the United States and Canada: who completes treatment and why?
    Int J Tuberc Lung Dis. 2015;19:31-8.
    PubMed     Text format     Abstract available


    November 2014
  473. FRICK M, Seaworth B, McKenna L, Elnour T, et al
    Cost-effectiveness of 12-dose LTBI regimen improved following advocacy to lower the price of rifapentine.
    Int J Tuberc Lung Dis. 2014;18:1386.
    PubMed     Text format    


    August 2014
  474. MARTINSON NA, McLeod KE, Milovanovic M, Msandiwa R, et al
    Implementation of isoniazid preventive therapy for HIV-infected adults: overstatement of district reports.
    Int J Tuberc Lung Dis. 2014;18:1005.
    PubMed     Text format    


  475. SANTUCCI N, Diaz A, Bianchi E, Spinelli S, et al
    Leptin does not enhance cell-mediated immune responses following mycobacterial antigen stimulation.
    Int J Tuberc Lung Dis. 2014;18:981-7.
    PubMed     Text format     Abstract available


  476. MAREKOVIC I, Bosnjak Z, Plecko V
    Direct identification of mycobacteria from smear-positive samples using real-time polymerase chain reaction.
    Int J Tuberc Lung Dis. 2014;18:978-80.
    PubMed     Text format     Abstract available


  477. SHIVARAMAKRISHNA HR, Frederick A, Shazia A, Murali L, et al
    Isoniazid preventive treatment in children in two districts of South India: does practice follow policy?
    Int J Tuberc Lung Dis. 2014;18:919-24.
    PubMed     Text format     Abstract available


  478. BAMRAH S, Brostrom R, Dorina F, Setik L, et al
    Treatment for LTBI in contacts of MDR-TB patients, Federated States of Micronesia, 2009-2012.
    Int J Tuberc Lung Dis. 2014;18:912-8.
    PubMed     Text format     Abstract available


  479. BONFIGLIOLI KR, Ribeiro AC, Moraes JC, Saad CG, et al
    LTBI screening in rheumatoid arthritis patients prior to anti-TNF treatment in an endemic area.
    Int J Tuberc Lung Dis. 2014;18:905-11.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: